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ABSTRACT 
 
3RO\F\VWLFRYDU\V\QGURPH3&26LVDFRQGLWLRQZKLFKFDQDIIHFWDZRPDQ¶V
menstrual cycle, fertility, hormones and aspects of her appearance. Polycystic ovaries 
are slightly larger than normal ovaries and have twice the number of follicles (small 
cysts). Polycystic ovaries are very common affecting a women.PCOS produces 
symptoms in approximately 5% to 10% of women of reproductive age (12±45 years old). The 
prevalence of PCOS depends on the choice of diagnostic criteria. About 18% of women had 
PCOS, and that 70% of them were previously undiagnosed. (Dalal-2011) 
 
Statement of the problem: Effectiveness ofself instructional module on knowledge 
regarding polycystic ovarian syndrome among adolescent girls in selected college 
atsivagangaiObjectives:To assess the pretest knowledge regarding polycystic ovarian 
syndrome among adolescent girls. To evaluate the effectiveness of self-instructional 
module on knowledge regarding polycystic ovarian syndrome among adolescent 
girls.To find out the association between the pretest knowledge regarding polycystic 
ovarian syndrome with their selected demographic variables. Conceptualframe 
work: It ZDV EDVHG 6KXIIOH %HDP¶V &,33 SURJUDPPH HYDOXDWLRQ PRGHO. Design: 
Evaluatory approach and Pre-experimental one group pre testpost testdesign was 
adopted for this study. Setting: The study was conducted in Vickram College of 
Engineeringat Sivagangai district. Sample size: The sample size was 100 adolescent 
girls.Sampling technique: The purposive sampling technique was used. Method of 
data collection procedure: Data were collected from the adolescent girls to assess 
the level of knowledge among the adolescent girls by using semi structured 
questionnaire  before and after self instructional module. The collected data were 
tabulated and analyzed by descriptive and inferential statistics. Results:Self 
Instructional Module was effective for adolescent girls according to the level of 
knowlege before and after the manipulation. The obtained t- value (44.7) was 
statistically highly significant at 0.05 levels.Conclusion: Thisstudy shown that Self 
Instructional Module had a significant effect in improving knowledge of adolescent 
girls. 
 
 
CHAPTER – I 
INTRODUCTION
1CHAPTER I 
INTRODUCTION
“No women should lose the ability to carry her child” 
- Devin smith 
Human life completes its journey through various stages and one of the most 
vital stages is adolescence. Adolescence is the period of transition from childhood to 
adulthood and plays a decisive role in the formation of pro-social/antisocial adult. All 
of us undergo this stage which poses many challenges and is full of excitement. At the 
same time it demands adjustment. When we come to this world we are completely 
dependent upon others and learn gradually to be independent. In India, the adolescents 
do most of the work themselves but the final decision regarding various domains of 
life is taken by their parents. (Human Development Module III -2010)
Adolescence has been identified as a distinct period in human development 
marked by biological changes beginning at the onset of puberty. With the arrival of 
puberty, hormonal changes particularly, the production of male and female hormones 
lead to an increase in sex drive. The first development task relating to sex, 
adolescence must master over forming new and more mature relationship with 
members of opposite sex. Based on their status of mind set Three main stages of 
adolescence can be discerned. Early adolescence (9-13years) characterized by a spurt 
of growth and the development of secondary sex characteristics. Mid adolescence (14-
15 Years) this stage is distinguished by the development of a separate identity from 
parents, of new relationship with peer groups and the opposite sex and age of 
experimentation. Late adolescence (16-19) at this stage adolescents have fully 
developed physical characteristics (similar to adults) and have formed a distinct 
identity well formed opinions and ideas (NCERT, 1999). 
The term adolescence derived from the Latin word ‘adolesco’, meaning “to 
grow” or “to grow to maturity” term adolescence has a broader meaning; it includes 
mental, emotional and social maturity. “To build a better future for all, we must 
ensure that energy a girl has not only the right but also the means to get an education 
and realize her dreams.”The term adolescence meaning “to emerge” or achieve 
2identity is a relatively new concept, especially in development of thinking the origin 
of the term is derived from the Latin word adolescent meaning “to grow to maturity” 
indicate the defining features of adolescence.
Adolescents form a major portion of countries population and development of 
the country depends upon healthy youth. Adolescence is critical growth spurt in one’s 
life. This is an age when adolescents are unaware and very men to know about their 
sexuality. Consequently get involved in different sexual activates. They may face 
many problems related to sexual issues and rights as they lack knowledge about 
physical, psychological changes accompanying their growth and development. 
Young people form precious human resources in every country. World Health 
Organization (WHO) defines ‘adolescence’ as age spanning 10 to 19 years, “youth” 
as those in 15-24 years age group and these two overlapping age groups as “young 
people” covering the age group of 10-24 years. Adults include a broader age range 
and all those in 20 to 64 yr. Adolescence is further divided into early adolescence (11-
14 years), middle adolescence (15-17 years), and late adolescence (18-21 years). 
Individuals in the age group of 20 - 24 years are also referred to as young adults. The 
National Youth Policy of India (2003) defines the youth population as those in the age 
group of 15-35 years. Population aged 10-24 years accounts for 373 million (30.9%) 
of the 1,210 million of India’s population with every third person belonging to this 
age group. Among them, 110 and 273 million live in urban and rural India, 
respectively. Males account for 195 million and females 178 million, respectively 
(Singh Sunitha-2013)
"Young people are the innovators, creators, builders and leaders of the future. 
But they can transform the future only if they have skills, health, decision-making, 
and real choices in life. Today's world record 1.8 billion young people present an 
enormous opportunity to transform the future," (Babatunde Osotimehim-2014)
Every third person in an Indian city today is a youth. The population in the 
age-group of 15-34 increased from 353 million in 2001 to 430 million in 2011. 
Current predictions are increase in the youth population to 464 million by 2021 and 
finally a decline to 458 million by 2026. By 2020, India is set to become the world’s 
youngest country with 64 per cent of its population. (The Hindu-2013)
3There are 1.2 billion adolescents (10í19 years old) today make up 18 per cent 
of the world’s population. More than half of all adolescents live in Asia. In absolute 
numbers, India is home to more adolescents around 243 million than any other 
country. It is followed by China, with around 200 million adolescents. (UNICEF-
2012)
India is the second most populous country in the world with total population 
of over 1081 million. Adolescents form a large section of population, about 22.5 
percent, that is, about 225 million. (Arvind Dubey-2009)
India has the world's largest youth population with 356 million people 
between the ages of 10-24 years. China is second with 269 million young people, 
followed by Indonesia (67 million), the United States (65 million), Pakistan (59 
million), and Nigeria with 57 million, Brazil with 51 million, and Bangladesh with 48 
million. (The United Nations Population Fund-2014)
Adolescent girls in India are a large invisible population, amounting to 113 
million, or 20% of the world’s adolescent girls, and are trapped in a society with 
socio-cultural practices and contrasting stages of development that leaves them 
powerless to make essential life-choices.
Worldwide, there are approximately 880 million adolescent girls and young 
women aged 15–24 years. Despite making up 12% of the world’s population, this 
population is often left without a voice or control of their own bodies.(World health 
organization-2014)
 There are 1.8 billion young people in the world and the majority live in 
developing countries. They are the largest generation of youth in history. 
Approximately half of them 900 million are adolescent girls and young women. 
(United Nations report-2012)
Adolescents – defined by the United Nations as those between the ages of 10 
to 19 are 1.2 billion in the world today. Nearly 90 per cent live in developing 
countries. Every year, 1.4 million adolescents die from road traffic injuries, 
complications of childbirth, suicide, violence, AIDS and other causes. Cause of 
adolescent death varies by region, and mortality patterns are associated with sex. In 
Latin America, injuries (including homicide) are the leading cause of death among 
4adolescent boys; in Africa, complications of pregnancy and childbirth are the leading 
cause among adolescent girls aged 15í19.Around 11 per cent of all births worldwide, 
or an estimated 16 million, are to girls aged 15–19 and the youngest mothers are the 
most likely to experience complications and die of pregnancy related causes. 
(UNICEF-2012)
 Adolescents (10-19 years) constitute 21.3% that is nearly 1/5th of total 
population of India. Adolescence in girls has been recognized as a special period 
which signifies the transition from girlhood to womanhood. This transitional period is 
marked with the onset of menarche, an important biological milestone. (Jailkhani 
M.K.sheetu-2014)
Adolescents aged between 10-19 years account for more than one fifth of the 
world’s population. In India, this age group forms 21.4 percent of the total population 
(National Youth policy 2003).
As a growing adolescent, problem related to Puberty is the main stress for both 
girls and boys. In adolescent girls, menstruation is a natural phenomena gifted by god, 
it starts when a girl attain puberty. Now a day’s Menstrual disorders (58.06%) are 
found to be the commonest gynecological problem in adolescents and are not 
corrected due to lack of knowledge and awareness about early menstrual disorders 
cause. (Jamal L-2011)
Gynaecological problems of adolescents occupy a special space in the 
spectrum of gynaecological disorders of all ages. Menstrual abnormalities are the 
common problems of adolescents.  Polycystic ovary syndrome (PCOS) is the 
commonest cause of an-ovulatory infertility. As there are no well-accepted criteria for 
diagnosis, the incidence of PCOS is not really known. However, it is postulated to be 
about 20-30% in the general population. Based on symptomatology incidence varies 
between 4-5% to 21% (menstrual abnormalities) and 3.5 to 9% (Hyperandrogenism). 
It is important to remember that, 40% of women with oligomenorrhoea, 84% of 
women with hirsuitism and 100% of women presenting with severe acne, have PCOS 
as their etiology. (The Hindu-2011) 
Poly Cystic Ovarian Syndrome is a relatively common endocrine disorder in 
women of reproductive age group. It is found in around 70% of women who have 
5ovulation difficulties leading to sub-fertility. Fertility problems experienced by 
women with Poly Cystic Ovarian Syndrome may be related to the elevated hormone, 
insulin or glucose levels, all of which can interfere with implantation as well as 
development of the embryo. (Rizvi Javad-2015)
Enlarged polycystic ovaries had been described almost a century before, Stein 
and Leventhal codified the association of polycystic ovaries with hyper-androgenism, 
amenorrhea, and infertility in 1935 in their eponymous syndrome, now commonly 
known as polycystic ovary syndrome (PCOS). PCOS is a multisystem, reproductive-
metabolic disorder characterized by hyperandrogenism and chronic an-ovulation. It is 
defined as an ovary with 12 or more follicles of 2 to 9 mm in diameter and/or ovarian 
volume of greater than 10 mm.using the National Institutes of Health definition, the 
prevalence is 4.5% to 11.2% in Alabama, 9% in Greece, and 6.5% in Spain. The 
prevalence of polycystic ovaries associated with metabolic abnormalities among 
Indian immigrants in Britain is particularly high. (Cheung P. Anthony, 2010)
Polycystic ovary syndrome (PCOS) is one of the most common female 
endocrine disorders. PCOS is a complex, heterogeneous disorder of uncertain 
etiology, but there is strong evidence that it can to a large degree and be classified as a 
genetic disease. PCOS produces symptoms in approximately 5% to 10% of women of 
reproductive age (12–45 years old). It is thought to be one of the leading causes of 
female infertility and the most frequent endocrine problem in women of reproductive 
age. Polycystic ovary syndrome (or PCOS) is common, affecting as many as 1 out of 
15 women and is diagnosed in women in their 20 years or 30years (Sabarirajan-2012)
Polycystic ovary syndrome (PCOS) is a condition which can affect a woman’s 
menstrual cycle, fertility, hormones and aspects of her appearance. Polycystic ovaries 
are slightly larger than normal ovaries and have twice the number of follicles (small 
cysts). Polycystic ovaries are very common affecting 20 in 100 (20%) of women. 
(Royal college guidelines committee-2010) 
PCOS produces symptoms in approximately 5% to 10% of women of 
reproductive age (12–45 years old). The prevalence of PCOS depends on the choice 
of diagnostic criteria. About 18% of women had PCOS, and that 70% of them were 
previously undiagnosed. (Dalal-2011) 
6Between 1 in 10 and 1 in 20 women of childbearing age has PCOS. As many 
as 5 million women in the United States may be affected. It can occur in girls as 
young as 11 years old. (U.S. Department of health and human services-2010) 
Polycystic ovarian syndrome (PCOS) is the 4thgynaecological problem of 
hospital admission. About 15 – 20 % of women in reproductive age group are affected 
by PCOS. A study conducted to understand the magnitude of polycystic ovarian 
syndrome(PCOS) with sample size of 257 volunteers who were examined with 
ultrasonography showedthat 22% were found to have polycystic ovaries. 
The World Health Organization criteria for classification of an ovulation 
include the determination of oligomenorrhea (menstrual cycle >35 days) or 
amenorrhea (menstrual cycle > 6 months) in combination with concentration of 
prolactin, follicle stimulating hormone (FSH) and estradiol. Almost 80% of an 
ovulation patient have normal serum FSH and estradiol levels and demonstrate very 
heterogeneous symptoms ranging from an ovulation, obesity, biochemical or clinical 
hyperandrogenism and insulin resistance. PCOS is the most common cause of an 
ovulation in women with normal serum FSH and estradiol levels. In PCOS, there is a 
so-called “follicular arrest”, i.e., several follicles develop to a size of 5–7 mm, but not 
further. No single follicle reaches the pre-ovulatory size (16 mm or more). The small 
ovarian follicles are believed to be the result of disturbed ovarian function with failed 
ovulation, reflected by the infrequent or absent menstruation that is typical of the 
condition.(Fazia Navas-2011) 
Almost 7 million women in the U.S. alone have PCOS and less than half know 
they have the syndrome. Public information and awareness of the symptoms and the 
serious nature of the disorder are crucial to identifying women in need of treatment. 
Every year September month is the National PCOS Awareness Month (PCOSA 
Today-2007)
Adolescents challenge is that PCOS is a systemic, complex disorder that needs 
to be actively managed by them for the rest of their life. They need to go to a deeper 
level and develop certain health practices that will help their body to naturally 
minimize the symptoms and long- term risks of polycystic ovary syndrome. 
7NEED FOR THE STUDY
Polycystic ovary syndrome is a heterogeneous endocrine condition that affects 
approximately 5% to 10% of women in the reproductive age group. Depending on the 
population being examined; however, prevalence rates as high as 26%have been 
reported. Obesity has been recognized as a major factor in the pathogenesis of PCOS. 
Estimates of the prevalence of obesity in women with PCOS vary from 35% to 60% 
(Cheung P.Anthony-2010) 
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting 
about 5 to 10% women of reproductive age group worldwide. It is also estimated to be 
the major cause of an-ovulatory infertility accounting for about 73% of cases. 
Variance in prevalence among population is thought to be dependent on ethnic origin, 
race and other environmental factors on the phenotype (Ehrmann-2005).  
According to a report conducted by the International Institute of Population 
Sciences, infertility is growing at an alarming pace, especially in the cities. Out of 
around 250 million individuals estimated to be attempting parenthood at any given 
time, 13 to 19 million couples are likely to be infertile.This study showed that 
infertility has risen by 50 percent in the country. (Rao Venkat-2011) 
A report indicated that up to 40% of women with polycystic ovarian syndrome 
have either impaired glucose tolerance or type 2 diabetes by age 40. In addition, with 
Polycystic ovarian syndrome, high levels of insulin stimulate the ovaries to produce 
large amounts of testosterone (A male hormone), which can possibly prevent ovaries 
from releasing an egg each month thus causing infertility. High testosterone levels can 
also cause excessive hair growth male pattern boldness and acne.  In patients with 
polycystic ovarian syndrome insulin resistance encourages the storage of fat and the 
production of excessive amounts of testosterone. (British journal of obstetrics and 
gynecology-2000)
The WHO estimates that more than 180 million people worldwide have 
diabetes. The number is likely to go double by 2030. India and China have the highest 
number of diabetes in the world and many are undiagnosed Diabetic tendency affects 
8a woman in each stage of her life. In the adolescent stage along with obesity it leads to 
menstrual irregularities and infrequent egg production- the so called polycystic 
ovarian syndrome (PCOS). Many of these young girls show insulin resistance with 
high blood sugars when challenged with glucose load. These young girls when they 
go for infertility treatment produce less quality eggs despite high dose of hormones 
and medicines and have poor pregnancy rates. (The Hindu-2011) 
In 2008, 40% of U.S women were diagnosed with polycystic ovarian 
syndrome (PCOS). In Australia PCOS appears to be the common cause of oligo-
ovulatory infertility affecting 20-35% infertile women. In India, the prevalence of 
PCOS in adolescence is 9.13 %. India has witnessed about 30% rise in Pcos cases in 
the last couple of years. This draws attention to the issue of early diagnosis in 
adolescent girls. In Karnataka, incidence of PCOS among adolescent is estimated to 
be 11-26%. 
PCOS women are 7.4 times more likely to experience heart disease than non-
PCOS women and it is estimated that 70% of PCOS women have abnormal lipid 
profiles, with cholesterol being the most common. (Ebrahimi et al, 2014). 
Lakshmi K.S, et.al., (2014) conducted a prospective observational study to 
assess the prevalence of pcos at a tertiary hospital in Kancheepuram. The study results 
revealed that 57 patients experienced oligomennorrhoea and remaining 10 patients 
had amennorrhoea, 32 patients had hirsutism, 18 patients had acne and 4patients had 
alopecia. The study concluded that it’s important to consider and treat pcos in order to 
prevent the risk for developing type-2 diabetes, dyslipidaemia, hypertension and heart 
diseases. 
PCOS is a clinical and public health issue because it adversely affects 
women's health and health-related quality of life and puts a significant strain on 
healthcare resources. PCOS and related complications are also a tremendous 
economic burden, and in 2006 the total annual cost to treat women with PCOS 
between the ages of 14 and 44 years was more than 430 million in the USA. 
Treatments for hirsutism and diabetes account for 14% and 40%, respectively, of the 
total healthcare costs related to PCOS. (Black M.H-2011) 
9Musmar Samar, et.al., (2013) conducted a cross sectional study to establish the 
prevalence of pcos among female university students at Najah. The sample size 
consists of 137 female students and the data were collected by using clinical interview 
and assessment. The study results revealed that the estimated prevalence of pcos was 
7.3% acne was the only studied risk factor among others to be statistically significant 
related to pcos patients (OR=8.430, P-Value=0.015). Clinical hirsutism was found in 
27% participants, 70% of whom had idiopathic hirsutism. 
Sivasankari K, Vanitha Jain, (2014) conducted a quasi experimental study to 
evaluate the effectiveness of planned teaching programme on pcos towards improving 
knowledge among adolescent girls and the sample size consists of 50 adolescent girls. 
The study results revealed that the comparison of mean value depicted that post test 
mean value (10.3) is greater than the pre test mean value (5.8). The paired t test value 
showed 16.36 which was highly significant at P< 0.0001 level. The study concluded 
that about 50% women population are affected with infertility because of pcos. Hence 
nurse researcher has a pivotal role in creating awareness among adolescent girls 
regarding pcos.
Polycystic ovarian syndrome (PCOS) has drawn a lot of attention in the recent 
years being the leading cause of infertility among women. During my clinical 
experience I saw more patients with infertility and also the main causes for those 
patients in polycystic ovarian syndrome. The incidence of Pcos is more among 
adolescents suffering from physical and psychological morbidity. Assessing 
adolescents regarding polycystic ovarian syndrome (PCOS) is desirable to understand 
this upcoming health issue and formulate effective programme to enhance the quality 
of life of the people. Improving knowledge among adolescents regarding prevention 
and early detection of polycystic ovarian syndrome (PCOS) can go a long way in 
taming the disease. From the above studies the investigator found adolescent girls 
have lack of knowledge regarding PCOS and its prevention at the primary level as 
they are neglecting taking care of the disease. Hence, the researcher is interested to 
educate the adolescent girls regarding polycystic ovarian syndrome (PCOS) and its 
prevention through self instructional module.
10
Statement of the problem 
Effectiveness of Self Instructional Module (SIM) on knowledge regarding 
polycystic ovarian syndrome (PCOS) among adolescent girls in selected college at 
Sivagangai
Objectives
1. To assess the pretest knowledge regarding polycystic ovarian syndrome among 
adolescent girls.
2. To evaluate the effectiveness of self-instructional module on knowledge 
regarding polycystic ovarian syndrome among adolescent girls. 
3. To find out the association between the pretest knowledge regarding polycystic 
ovarian syndrome with their selected demographic variables. 
Operational definitions 
Effectiveness: In this study, it refers to the extent to which the self instructional 
module will achieve desired effect to gaining knowledge regarding polycystic ovarian 
syndrome in terms of difference between pre test and post test knowledge measured by 
semi structured questionnaire. 
Self instructionalmodule:In this study it refers self-learning information 
prepared for adolescent girls to improve the knowledge on poly cystic ovary 
syndrome which includes anatomy and physiology of ovaries, definition, incidence, 
etiology, pathophysiology, clinical manifestation, management, complicationsof 
PCOS. 
Knowledge: In this study, it refers to the facts, information acquired through 
education by adolescent girls regarding polycystic ovarian syndrome as elicited 
through a self administered questionnaire. 
Polycystic ovarian syndrome: Polycystic ovary syndrome (PCOS) is 
heterogeneous disorder characterized by excessive androgen production by the 
ovaries ,which interferes with the reproductive,endocrine,metabolic functions 
manifested byamenorrhea,hirsutism and obesity associated with enlarged polycystic 
ovaries.
11
Adolescents: Girls aged between 16-19 years studying in vickram engineering 
college
Hypotheses
H1: There is a significant difference between pretest and posttest knowledge 
regarding polycystic ovarian syndrome among adolescent girls. 
H2: There is a significant association between pretest knowledge with their 
selected demographic variables. 
Assumptions
The study assumes that, 
 Adolescents girls were not aware about polycystic ovarian syndrome 
 All polycystic ovarian syndrome girls have increased body mass index 
 Education about polycystic ovarian syndrome will improve the knowledge 
of adolescent girls. 
Limitations
  The limitations of the study were 
 The study focused only on adolescent girls not other age group peoples 
 The study focused only on 1 year adolescent girls not other year adolescent 
girls
 Control group and randomization can be done to improve the effectiveness in 
this study. 
12
Conceptual framework
  The present study aims at evaluating the effectiveness of Self Instructional 
Module on knowledge regarding Polycystic Ovarian Syndrome among Adolescent 
girls. The framework of the present study based on Shuffle Beam’s CIPP 
Programme Evaluation model, 1960. CIPP is an acronym that stands for Context, 
Input, Process and Product. 
Context:
  It provides information for the development and evaluation of mission, 
vision, values, goals and objectives.In this study context consist of socio demographic 
variables of the adolescent girls such as age, religion, mother’s education, mother’s 
occupation, economic status, area of residence, type of family, previous information, 
body mass index, age at menarche, duration of menstruation and interval between 
menstruations.
Input:
 It helps to assess different teaching and learning approaches. It includes 
designing of intervention programme.In this study input is the Self Instructional 
Module prepared on the basis of learning needs.
Process:
Process evaluation assesses the implementation of plans. In this study process 
evaluation refers to evaluating the pre test and post test.
Product:
 It is the evaluation of the outcome of the programme.In this study product is 
the improved response of the adolescent girls followed by the implementation of Self 
Instructional Module
13
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CHAPTER II 
REVIEW OF LITERATURE
 The extensive review was made to strengthen the present study in order to 
lay down the foundation which helps us to reveal the prevailing situation of the 
similar studies in different areas. The related literature of this study was presented in 
the following sections: 
¾ Literature related to prevalence of polycystic ovarian syndrome 
¾ Literature related to causes/risk factors of polycystic ovarian 
syndrome 
¾ Literature related to diagnosis of polycystic ovarian syndrome 
¾ Literature related to management of polycystic ovarian syndrome 
¾ Literature related to complication of polycystic ovarian syndrome 
¾ Literature related to education program on knowledge of polycystic 
ovarian syndrome 
Literature related to prevalence of polycystic ovarian syndrome 
Maha. A et.al., (2013) conducted a retrospective cross sectional study to 
determine the prevalence of Pcos among omani women of reproductive age groups 
from 2006-2010. The study results revealed that the prevalence of Pcos per 1000 
patients in 2010 was 2.8%. The highest prevalence was in the muscat region (42%) 
followed by Dhakliya and Al batinah regions. 
Moran.et.al., (2010) conducted a prospective cross sectional study to 
determine the prevalence of Pcos in a sample of Mexican women aged 20-45 years. 
The study results revealed that 9 of the 150 women were diagnosed with Pcos. All 
Pcos patients presented oligo ovulation, 9 had hirsutism and 7 of them had acne. 8 of 
the 10 Pcos patients had morphologic characteristics of Pcos in Mexican women is 
approximately 6.0%, similar to other populations, but lower than 12.8% repeated in 
Mexican-American women. 
Loft A et.al., (2014) conducted a prospective cross sectional study to assess 
the prevalence of Pcos in a normal population. The study results revealed that the 
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Pcos prevalence significantly decreased with age from 33.3% in women < 30 years to 
14.7% in women aged 30-34 years and 10.2% in women > 30 years (P<0.001). The 
study concluded that there is an need for further studies to validate the results with 
other biochemical analyses. 
GowriVaidyanathan et.al., (2013) conducted a retrospective cross sectional 
study to determine the hospital based prevalence of Pcos among Omani women of 
reproductive age group of 12-45 years who attended the gynaecology clinic in a 
tertiary hospital in Oman. the study results revealed that the overall prevalence of 
Pcos per 1000 patients in 2010 was 2.8%. The study concluded that the prevalence of 
diagnosed Pcos cases among women in Oman is similar to that of other countries. 
Norman J Robert et.al (2009) conducted a retrospective cohort study to 
estimate the prevalence of Pcos in the community under the national institute of 
health criteria. The sample size consists of 728 women born during 1973-1975 (age = 
27-34 years). The study results revealed that the prevalence of Pcos was 8.7 ± 2.0%. 
The study concluded that more attention should be given to the issues of women with 
Pcos in the community. 
Farhad et.al (2011) conducted a descriptive study to estimate the prevalence of 
Pcos in a community based sample in Iran. The sample size consists of 1126 women 
were selected by using multistage probability cluster sampling method. The data were 
collected by using the ultrasonographic parameters, hormonal profiles and clinical 
histories. The study results revealed that the estimated prevalence of idiopathic 
hirsutism was 10.9%; 8.3% of women had only oligo/an ovulation and 8.0% had only 
polycystic ovaries.
Li Lin et.al., (2008) conducted an observational study to determine the 
prevalence of Pcos in selected women from Southern China. The study results 
revealed that the 2.2% (20/915) prevalence of Pcos. Women with Pcos had higher 
levels of LH and FSH. The study concluded that some clinical and biochemical 
characteristics were apparent in Pcos patients in our population. 
Cunningham Joan et.al., (2012) conducted a cross sectional survey to 
document the prevalence of Pcos and its associated characteristics in a sample of 
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Urban indigenous women living in Darwin, Australia and Northern territory.  The 
study results revealed that among 248 women, the proportion who had Pcos was 
15.3% (95% CI: 10.8%-19.8%). The study concluded that the significant relationship 
with obesity gives a strong rationale for screening for Pcos during routine care of 
indigenous women who are obese and of reproductive age. 
 Hart R et.al., (2011) conducted a prospective cohort study to determine the 
prevalence of metabolic syndrome in adolescents with Pcos.  The study results 
revealed that the prevalence of metabolic syndrome recorded was 11.8% in girls with 
Pcos and 6.6% (Rotterdam) (Non Pcos 0.6% and 0.7% respectively). Menstrual 
irregularity and polycystic ovary morphology were not associated with insulin 
resistance (56.3% vs 52.9% and 60.0% vs 34.4% respectively).The study concluded 
that the prevalence of metabolic syndrome in girls with Pcos, one third have features 
putting them at high risk for development of metabolic syndrome. 
Smith Ninget.al., (2013) conducted a cross sectional study to investigate the 
prevalence of polycystic ovary syndrome (PCOS) in adolescents and its association 
with obesity. The study results revealed that the prevalence of a confirmed diagnosis 
of Pcos was 0.56%, which increased to 1.14% when undiagnosed cases with 
documented symptoms qualifying for Pcos according to NIH criteria were included. 
Compared with normal/underweight girls, the odds ratios (OR and 95% confidence 
interval [CI]) for confirmed Pcos diagnosis were 3.85 (3.04-4.88), 10.25 (8.16-12.84), 
and 23.10 (18.66-28.61) for overweight, moderately obese, and extremely obese 
adolescents, respectively, after adjusting for potential confounders. The study 
concluded that the prevalence of Pcos and overestimate the magnitude of the 
association between obesity and Pcos. 
Musmar Samar et.al., (2013) conducted a cross sectional study to establish 
prevalence of Pcos among female university students at An-Najah National 
University-Palestine and to explore its possible risk factors. The sample size consists 
of 137 female students aged between 18-24 years by using convenient sapling 
technique. The data were collected by interview and clinical assessment method. The 
study results revealed that the estimated prevalence of Pcos was 7.3% , acne was the 
only studied risk factor among others to be statistically significantly related to Pcos 
patients (OR=8.430, P-value=0.015). Clinical Hirsutism was found in 27% of 
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participants, 70% of whom had idiopathic hirsutism. The study concluded that the 
Prevalence of Pcos in Palestine seems to be relatively high but similar to other 
Mediterranean statistics. 
Literature related to causes/risk factors of polycystic ovarian syndrome 
Bronstein Jason et.al., (2011) conducted a retrospective study to compare the 
risk factors involved in causing Pcos in adolescents and pre adolescent girls. The 
study sample size consists of 58 preadolescent and adolescent girls. The data were 
collected by using family history and biochemical analyses. The study results revealed 
that there were 26% (15/58) preadolescent girls (9-12years) vs. 74% (43/58) 
adolescents (13-18 years). The study concluded that there is a need for awareness 
among young girls regarding Pcos. 
Legro R S et.al (2011) conducted a cross sectional case control study to 
determine the factors associated with an increased risk of the metabolic syndrome in 
Pcos. The study results revealed that 37% of adolescent girls with Pcos had metabolic 
syndrome compared with 5% of national health and nutrition examination survey girls 
(P<0.0001). None of the girls of normal BMI had metabolic syndrome, whereas 11% 
of overweight and 63% of obese girls with Pcos had metabolic syndrome compare 
with o and 32% of national health and nutrition examination survey girls respectively. 
The study concluded that adolescent girls with Pcos have a higher prevalence of 
metabolic syndrome than the general adolescent population 
Literature related to diagnosis of polycystic ovarian syndrome
 Mujeeb Saba et.al., (2008) conducted a cross sectional study to determine 
the diagnostic threshold of ultrasound in detecting Pcos and to correlate it with 
clinical, hormonal and laparoscopic findings of polycystic ovarian disease. The study 
results revealed that the sensitivity of ultrasound in diagnosing Pcos is 87.7% and 
specificity is 99%. The sensitivity and specificity of S. LH, S. Prolactinand S. Insulin 
are 38% and 100%, 13% and 90%, and 68% and 50% respectively. 
Sahmay S et.al., (2013) conducted a cross sectional study to  determine the 
possible role of anti-Mullerian hormone (AMH) in the diagnosis of polycystic ovary 
syndrome with a larger population of women and to evaluate its role as a new 
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diagnostic marker.  The study concluded that Serum Anti Mullerian hormone 
measurement is very valuable in the diagnosis of PCOS women. The serum Anti 
Mullerian hormone level is a new and useful diagnostic tool in PCOS diagnosis.
Ali Khan Naveedet.al., (2014) conducted a case control study toexamine the 
association of adiponectin levels in young and lean women with PCOS. The study 
concluded that the adiponectin level may serve as a potential independent biomarker 
for diagnosis of Pcos in young and lean women with fewer symptoms, or women with 
a family history of Pcos.  
Swalem A M et.al., (2012) conducted a prospective study to assess the 
frequency of clinical and biochemical features of PCOS. The study concluded that the 
chronic an-ovulation and hirsutism are the dominant features of PCOS in our patient 
population. More than half were obese, and the prevalence of diabetes, hypertension 
and thyroid disease in our patients seemed to be underestimated in comparison to 
other parts of the world. 
Mariana, NechitaAurel., (2013) conducted a descriptive study to compare the 
ovary morphologic data in different types of ultrasound imaging in adolescents.The 
study concluded that ultrasound imaging remains the main method of assessment for 
genital organs at young ages.
Literature related to treatment of polycystic ovarian syndrome 
T.I siebert et.al.,(2011) conducted meta-analysis and systematic review to 
determine that metformin(M) is highly effective for ovulation induction in 
theclomiphene citrate (CC)-resistant patient. 1.6, p =0.05) the study revealed that the 
combination (CC+M) is superior to CC alone asa primary method for ovulation 
induction and to achievepregnancy in PCOS.
Tahira Dar et .al., (2011) conducted an observational study to assess  the 
effectiveness and benefits of metformin in patients with poly cystic ovarian syndrome 
treatment. The study was concluded that there is lack of large scale clinical trials of 
metformin therapy in PCOS and of studies comparingdifferent treatments. There is 
still need of study on large population for more accurate and preciseresults, as smaller 
trials tend to be less reliable and hence may produce conflicting results.
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Amrudabennel,sudhakerure (2011) conducted a case control study to  know 
the effect of PCOS on glucose metabolism in younger age group.PCOS patients 
compared to normal menstruating women .the study was concluded that PCOS 
patients are more prone for impaired glucose tolerance and type 2 Diabetes Mellitus. 
So they should screen for impaired glucose tolerance and type 2 Diabetes Mellitus to 
prevent complications. 
 Daniela romualdi et.al.,(2011) conducted a prospective longitudinal study to 
detailed examination of glucose and insulin metabolism in pregnant women with 
PCOS undergoing metformin therapy...the study was concluded that Women with 
PCOS who enter pregnancy in a condition of severe hyperinsulinemia have 
development of GD earlier, independently of metformin treatment. The physiologic 
deterioration of insulin sensitivity is not affected by the drug and does not predict the 
timing and severity of the glycemic imbalance. Despite the high incidence of GD 
observed, the drug itself or the intensive monitoring probably accounted for the good 
neonatal outcome.
Dr. fauziahaqnawaz,Dr.javedrizvi(2015) conducted a Nested case Control 
study  To compare the effectiveness of Metformin along with Clomiphene citrate as a 
primary and adjunct therapy in Clomiphece resistant infertile women with PCOS at  
Infertility clinic of Aga Khan University Hospital, Karachi, Pakistan. The study was 
concluded that Metforminimproves pregnancy and   live birth rate when added with 
Clomiphene citrate and Clomiphene resistant women with PCOS even with 
normal insulin status. 
 Ashraf jamal et.al.,(2012) conducted a comparative study To determine and 
compare utero-placental circulation and obstetrics complications in pregnant women 
with PCOS treated with metformin, aspirin and control group. The study was 
concluded that Metformin and low dose aspirin reduced uterine artery impedance but 
there was not associated with reduced obstetrics complication in women with PCOS. 
 Malkawi HY et.al.,(2014) conducted a prospective  study  to evaluate the 
efficacy of metformin compared with ovarian drilling in the treatment of clomiphene 
citrate (CC) resistant women with polycystic ovary syndrome. (64.1% vs 59.8%).  
The study was concluded that CC-resistant patients with polycystic ovary syndrome 
can be treated effectively either by metformin or by laparoscopic ovarian drilling. 
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Menstrual cycle pattern and the rates of ovulation and pregnancy are improved 
significantly, due most probably to the significant decrease in the levels of androgens 
and luteinizing hormone.
Rouziaa,Ardawi MS (2006) conducted a randomized controlled trial study  
to compare the efficacy and safety of clomiphene citrate and low-dose recombinant 
FSH as first line pharmacological therapy for an-ovulatory infertility associated with 
polycystic ovary syndrome (PCOS).. The study was concluded that that low-dose 
recombinant FSH may be an effective alternative to clomiphene citrate in first-line 
treatment for an-ovulatory PCOS patients. Thus, further studies, possibly multi-
centre, in order to avoid problems with patient recruitment, are warranted to confirm 
these results. 
 Dubourdieu S, et.al.,(2013) conducted a prospective, randomized study To 
compare the efficacy of pulsatile GnRH therapy versus combined gonadotropins for 
ovulation induction in women with both hypothalamic amenorrhoea and polycystic 
ovarian syndrome (HA/PCOS) according to their current hypothalamic status in the 
Nantes University Hospital, France . The study was concluded that HA/PCOS is a 
specific subgroup of infertile women. Pulsatile GnRH therapy is an effective and safe 
method of ovulation induction that can be used successfully in these patients. 
 Kamel H (2013) conducted a Prospective randomized controlled study to 
assess the role of a phyto-oestrogen, in ovulation induction in women with polycystic 
ovarian syndrome (PCOS).l in Minia University Hospital, Minia, Egypt.  The study 
was concluded that Phyto-oestrogen can be used as an alternative to clomiphene 
citrate for ovulation induction in women with polycystic ovarian syndrome
Literature related to complications of polycystic ovarian syndrome 
 Jun z qin et.al.,(2013) conducted a meta-analysis to determine obstetric 
complications in women with polycystic ovary syndrome..The study concluded that 
women with pcos have increased risk of adverse pregnancy and neonatal 
complications. It is necessary to establish guidelines for supervision during pregnancy 
and parturition to prevent these complications.
Resheftal et.al.,(2013) conducted a prospective cohort study to determine 
the increased angiogenesis and hypervascularity in pcos women.  This 
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studyconcluded that of an alteration in the Ang-1/Ang-2 system in PCOS women. The 
biological role of Ang-2 in promoting capillary leakage, the increased Ang-2 FF level 
in PCOS, and its correlation with number of oocytes suggest that Ang-2 may play an 
important role in the increased risk of ovarian hyper stimulation in PCOS. 
Dokras A et.al.,(2007  ) conducted a meta-analysis and systematic review to examine 
prevalence of  anxiety symptoms in women with pcos and control women. 
pcoscompared with control subjects. The study concluded that increased odds of 
anxiety symptoms in women with pcos, undergoing the importance of screening all 
women with pcos for anxiety symptoms. Follow up evaluation and treatments are 
essential. 
Teresa sir petermann et.al.,(2005) conducted a compared study to establish the 
birth weight of newborn of  mothers with pcos and to compare it with a control group 
of mewborns of normal women matched by age and weight at the beginning of 
pregnancy. The study was concluded that PCOS mothers showed a significantly 
higher prevalence of SGA newborns which cannot be completely attributed to 
pregnancy complications, and seems to be more related to the PCOS condition of the 
mother.
 Rupalsharoff B.S et.al.,(2007)conducted a retrospective study to determine the 
risk of metabolic complications, primarily metabolic syndrome in all polycystic 
ovarian syndrome phenotypes compared with control subjects. 8.2(2.3-29.3).there was 
no significant difference in the prevalence of insulin resistance and glucose 
intolerance was not significantly different between pcos phenotypes. The study was 
concluded that the risk of metabolic syndrome may vary among the four phenotypes 
of pcos based on the criteria. 
Yildir IC; Kutluturk F et.al.,(2013) conducted a prospective study to determine 
the insulin resistance in women with PCOS patients who have normal oral glucose 
tolerance test (OGTT) and to evaluate cardiovascular risk by measuring C-reactive 
protein (CRP) and carotid intimae-media thickness (CIMT) . There was a no 
significant difference between patients and controls in BMI, and waist circumference, 
lipid, TSH, LH, FSH, estradiol, and prolactin levels. Serum insulin, testosterone, 
DHEAS, ferritin levels and HOMA values were significantly higher in patient group. 
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We found that 64.7% (n = 22/34) patients with PCOS had insulin resistance. Both of 
CIMT and CRP levels were significantly higher in the PCOS patients had BMI over 
25 kg/m². CRP levels was significantly higher in the PCOS patients had waist 
circumference greater than 80 cm. the study concluded that insulin resistance in the 
women with PCOS even if OGTT was normal. Our data were similar to literature; the 
women with PCOS have increased risk of premature atherosclerosis and metabolic 
syndrome. 
Literature related to knowledge of polycystic ovarian syndrome 
Katie callwellet.all.,(2010) conducted a clinical research study to assessed 
changes inKnowledge, feelings, and daily health practices related to PCOS.  The 
study was concluded thatWomen with PCOS felt that they had more knowledgeand 
motivation to implement preventive health strategies afterparticipating in a clinical 
research study. Education about howPCOS affects their immediate and long-term 
health enabledwomen with PCOS to feel physical and psychological benefits andto 
engage more with their health care providers.
 Sowmiya et.al.,(2013) conducted a experimental study to assess the 
effectiveness of structured teaching programme on knowledge of polycystic ovarian 
syndromeamong adolescent girls.  A significant difference between pre test and post 
test knowledge was found (t 2.0 79=p<0.05).The study findings showed that the 
structured teaching programme was effective in improving knowledge of adolescent 
girlsregarding polycystic ovarian syndrome. There was no significant association 
between the level of knowledge and demographic variablesexcept the group in which 
they study (Science, Arts, Commerce).
 Leicester (2011) conducted a interventional study aims to develop and test a 
programme that can be run in groups (structured education), to support women with 
PCOS make the lifestyle changes needed to improve their PCOS and prevent future 
associated health problems. Structured education programmes are suitable for use 
within the NHS and are already recommended for individuals with T2DM, but have 
not been tested as a method of treatment for PCOS which is a high risk condition for 
T2DM.. The study was concluded that the investigators believe that the group given 
the structured education will show some evidence of improvement in their glucose 
metabolism, and consequently decreased chance of developing diabetes.
CHAPTER – III 
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CHAPTER – III 
RESEARCH METHODLOGY 
 This chapter deals with the methods adopted by the research to find out the 
effectiveness of self instructional module on knowledge regarding polycystic ovarian 
syndrome. It deals research approach, research design, the setting, population, and 
sample size, sampling technique, development cum description of tool, validity, 
reliability, pilot study and procedure for data collection for data analysis 
Research approach 
 Evaluatory approach was used in this story. It aimed to evaluate the 
effectiveness of self instructional module on knowledge regarding polycystic ovarian 
syndrome. 
Research design 
 Pre experimental one group pre testpost test design was adopted for this study 
GROUP PRETEST EXPERIMENT POST TEST 
     E             O1                    X                   O2
FIG-2: DIAGRAMMATIC REPRESENTATION OF RESEARCH DESIGN
 E - Experimental group 
 01 – Pretest assessment of knowledge regarding polycystic ovarian syndrome 
  X - Self instructional module 
 02- Posttest assessment of knowledge regarding polycystic ovarian syndrome 
Variables under the study 
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Independent variables: Self instructional module rendered by the research to 
the adolescent girls on polycystic ovarian syndrome was independent variable in this 
study
Dependent variables: Knowledge of adolescent girls regarding polycystic 
ovarian syndrome was dependent variable in this study.
Setting of the study 
The study was conducted in Vickram Engineering college at Sivagangai 
whichis about5 kms away from our nursing institute.
Study population 
Target population:Adolescent girls . 
Accessible population:Adolescent girls studying in Vickram College of 
Engineering at Sivagangai district
Sample 
 Adolescent girls who fulfill the inclusion criteria will be consider as a sample. 
Sample size 
 Sample size consists of 100 adolescent girls studying at selected college in 
Sivagangai.
Sample technique 
 Non probability – purposive sampling technique was used for this study. 
Criteria for sample selection
The samples are selected based on the following inclusion and exclusion 
criteria.
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Inclusion criteria:The study includes,
1. Adolescent girls who were studying 1 year B.E (computer engineering) in 
Vickram College of engineering. 
2. Willing to participate 
3. Available at data collection 
Exclusion criteria
1. Adolescent girls who were already  diagnosed and in treatment of  polycystic 
ovarian syndrome 
2. Adolescent girls who were sick at data collection . 
Research tool and technique 
 The instruments used in this research study consist of two section. 
Section A 
 It comprised of demographic variables such as age, religion, mother’s 
occupation, and economic status, type of family, area of residence, previous 
information, measurements, and details of menstruation. 
Section B 
 It comprised of semi structured questionnaire to assess the adolescent girls 
knowledge regarding polycystic ovarian syndrome. It was edited as per the blueprint 
and different content area. It consist of 30 multiple choices question. Fact ideal had 
four choices out of which one were correct answers and the remaining there where 
wrong answers. A score value of ‘one’ was allotted to each correct response. ‘zero’ 
was rewarded for the wrong response. Thus there were so maximum obtainable 
scores. The level of knowledge was graded based on percentage of scores obtained 
Level of knowledge 
 Above 75 (adequate) 
 50 – 75     (moderate) 
 Below 50 (inadequate) 
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Section c 
 It comprised self instructional module on knowledge regarding polycystic 
ovarian syndrome among adolescent girls. The content on polycystic ovarian 
syndrome was selected through literature search and in consultation with experts. The 
content of the self instructional modules was organized well by the following 
headings
 Anatomy of ovaries 
 Function of ovaries 
 Normal levels of hormone 
 Definition of polycystic ovarian syndrome 
 Incidence of polycystic ovarian syndrome 
 Risk factors of polycystic ovarian syndrome 
 Etiology of polycystic ovarian syndrome 
 Pathophysiology of polycystic ovarian syndrome 
 Clinical manifestation of polycystic ovarian syndrome 
 Diagnostic evaluation of polycystic ovarian syndrome 
 Life style modification of polycystic ovarian syndrome 
 Medical management of polycystic ovarian syndrome 
 Surgical management of polycystic ovarian syndrome 
 Complications of polycystic ovarian syndrome 
Testing the tool: 
Content validity 
 Assessment tool was evaluated by experts from the field of nursing and 
medicine for content validity. Suggestions were considered and appropriate changes 
were done and to made the tool to be valid. 
Pilot study
Pilot study was conducted in Vickram Engineering college for the period of 
one week on 10 adolescent girls in order to test the feasibility, relevance and 
practicability of the tool. Result shows that the tool was feasible to carry out the main 
study.
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Reliability
 The data were collected from 10 samples to find out the reliability. The split 
half method was used to establish the reliability of the tool. This was done by splitting 
the items into odd and even items. The reliability coefficient of the whole test then 
estimated and the value obtained was (r=0.94) which indicates that tool is reliable.
Data collection procedure
 The investigator met the head of the institution in order to establish support 
and co-operation to conduct the study successfully. The formal prior permission was 
obtained from the principal, Vickram College of engineering, sivgangai for main 
study. The investigator introduced her to the adolescent girls and established rapport 
with them. The study was conducted for period of two weeks. The investigator 
selected the sample that fulfilled the inclusion criteria. The informed consent was 
obtained from Vickram  Engineering College. Appropriate orientation had given to 
the subjects about the aim of the study, nature of questionnaire and adequate care was 
taken for protecting the subjects from potential risk including maintain 
confidentiality, security and identity. The demographic variables collected from the 
subjects. The pre test was done to assess the adolescent girl’s knowledge through semi 
structured questionnaire. Self instructional module was administered. The post test of 
study was carried out one week later, using same tool as the pre test. Collected data 
was then tabulated and analyzed.
Plan for data analysis
Data analysis was done according to the objectives of the study. Both 
descriptive and inferential statistics were used.
1. Analysis of the demographic data was done by frequency, mean, 
percentage.
2. Paired‘t’ test was used to determine the difference between the pre test and 
post test score interms of effectiveness of self instructional module. 
3. Chi square test was used to determine the association between the selected 
demographic variables. 
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Protection of human rights
Research proposal was approved by the dissertation committee, RASS 
academy college of Nursing, Poovanthi. Prior to the study oral consent of each 
teachers was obtained before starting the data collection. Assurance was given to the 
teachers that confidentiality would be maintained. 
CHAPTER- IV 
DATA ANALYSIS 
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CHAPTER-IV
ANALYSIS AND INTERPRETATION OF DATA 
 This chapter deals with the analysis and interpretation of the data 
collected from adolescent girls who have received the self instructional module. The 
collected data were tabulated, analyzed and presented. It consists of the following 
sections:
Section I : Description of adolescent girls according to their selected demographic
variables
Section II : Description of adolescent girls according to their selected obstetric
variables
Section III : Description ofadolescent girls according to their pretest and posttest
knowledge level ofregarding polycystic ovarian syndrome. 
Section IV : Comparison of pretest and posttest knowledge level of adolescent
girls  onpolycystic ovarian syndrome. 
Section V  : Association of pretest knowledge level of adolescent girls with their
selected demographic variables. 
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SECTION – I 
Description of adolescents according to their selected demographic 
variables 
Table 2-Distribution of adolescent’s girls according to their selected 
demographic variables 
S.NO Demographic variables 
           Adolescent girls 
Frequency Percentage (%) 
1.
2.
3.
Age( in years) 
a)16 – 17
          b)18 – 19 
Religion 
          a)Hindu 
          b)Christian 
          c)Muslim 
Mother’s Educational Status 
          a)Illiterate 
          b)High school 
          c)Higher secondary 
          d)Under graduate
          e)Post graduate
65
35
86
14
0
25
27
35
13
0
65
35
86
14
0
25
27
35
13
0
31
  4. 
        5. 
        6. 
       7. 
      8. 
Mother’s occupation  
          a)Housewife 
          b)Private employee 
          c)Gout employee 
Type of  Family 
          a)Nuclear 
          b)Joint 
Economic status 
          a)Lower class  
          b)Middle class 
          c)Upper class 
Area of  Residence
          a)Rural
          b)Urban 
Source of Information  
          a)Through Family members 
          b)Friends 
          c)Mass media  
          d)No previous information 
72
28
0
85
15
0
100
0
26
74
0
4
4
92
72
28
0
85
15
0
100
0
26
74
0
4
4
92
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Table-2 summarizes that demographic characteristics of adolescents among 
100, with regards to age (65%) were 16 – 17 years, (35%) were 18 – 19 years, with 
regards to religion, majority of the samples (86%) belongs to Hindu and (14%) were 
Christians and no Muslims. Regarding mother’s educational status, (25%) were 
illiterate, (27%) had high school,(35%) were higher secondary school,(13%) were 
under graduate and no post graduate. Regarding to mother’s occupation majority of 
the samples (72%) was Housewife, (28%) were private employee and no Government 
employee. with regards to type of family (85%) were Nuclear and (15%) were Joint 
family. Distribution of subjects with reference to Economic status (100%) was middle 
class and no lower class and upper class. With regards to Area of Residence (26%) 
were rural and (74%) were Urban. With regards to Source of information majority of 
the samples (92%) belongs to No previous information, and (4%) were from mass 
media, (4%) from friends. 
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Table-3 Description of adolescents according to their selected obstetric 
variables 
S.NO OBSTETRIC VARIABLES 
ADOLESCENT GIRLS
Frequency Percentage (%) 
1.
2.
3.
4.
5.
Body mass Index 
a) Low weight 
b) Normal 
c) Over weight 
d) Obesity 
Age at menarche (yrs) 
a) Below 13 
b) 13 – 15 
c) Above 15 
Duration of menstruation 
a) Below 3 days 
b) 3 – 5 days 
c) Above 5 days 
Interval between menstrual 
cycle
a) Below 1 month 
b) 1 – 2 month 
c) Above 2 month 
Bleeding
a) Normal 
b) No bleeding 
c) Mild bleeding 
d) Severe bleeding
27
66
7
0
15
85
0
0
82
18
7
93
0
67
0
26
7
27
66
7
0
15
85
0
0
82
18
7
93
0
67
0
26
7
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Table -3 predicts that, 
         Regarding Body mass index majority of samples (66%) belongs to overweight, 
(27%) were low weight, (7%) belongs to overweight and no one belongs to obesity 
    Regarding Age at menarche (85%) belongs to 13 – 15 yrs, (5%) belongs to below 
13 years and no one in above 15 years 
 Regarding duration of menstruation majority of the sample (82%) belongs to 3 
– 5 days. Regarding interval between menstrual cycles (93%) belongs to 1 – 2 
months, (7%) were below 1 month and no one belongs to above 2 months. 
            Regarding bleeding (67%) belongs to normal bleeding, (26%) mild bleeding, 
(7%) belongs to severe bleeding and no one belongs to no bleeding. 
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Figure 2: Distribution of adolescent girls according to their age in years 
Figure 3: Distribution of adolescent girls according to their religion 
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Figure 4: Distribution of adolescent girls according to their mother’s 
education
Figure 5: distribution of adolescent girls according to their mother’s 
occupation
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Figure 6: Distribution of adolescent girls according to their type of family
Figure 7: distribution of adolescent girls according to their economic 
status
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Figure 8: Distribution of adolescent girls according to their area of 
residence
Figure 8: distribution of adolescent girls according to their source of 
information
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Figure 9: Distribution of adolescent girls according to their body mass 
index
s
Figure 10: Distribution of adolescent girls according to their age at menarche
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Figure 11: Distribution of adolescent girls according to their duration of 
menstruation
Figure 12: Distribution of adolescent girls according to their interval 
between menstrual cycle 
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Figure 13: Distribution of adolescent girls according to their bleeding
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SECTION – II
Description of adolescents according to the pretest and posttest 
knowledge level on polycystic ovarian syndrome 
Table 3-Description of adolescents according to the pretest and posttest 
knowledge level on polycystic ovarian syndrome  
S.NO Level of knowledge 
Pretest Posttest 
F Mean % F Mean % 
1.
2.
3.
Above 75 ( Adequate ) 
50 – 75 (Moderate) 
Below 50 (Inadequate) 
0
26
74
0
0.26
0.74
0
26
74
92
8
0
0.92
0.08
0
92
8
0
 Table-3 depicts that, the pretest and posttest level of knowledge. Majority 
(74%) of adolescent had inadequate knowledge,(26%) had moderate knowledge. No 
one scored adolescent (above 75) marks in pretest but in the posttest majority (92%) 
of adolescents had adequate Knowledge (above 75) and only (8%) of them scored 
moderate knowledge level (50 – 75). 
 The above finding summarizes that, the self instruction module has significant 
beneficial effect in the level of knowledge among adolescent girls. 
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Figure 14: Distribution of adolescent girls according to their pre test and 
post testknowledge level 
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SECTION – III
Comparison of pretest and posttest knowledge level of adolescents 
on polycystic ovarian syndrome  
Table 4-Comparison of pretest and posttest knowledge level of adolescent girls 
(Significant at 0.05 level) 
 The above table depicts comparison of mean pretest and posttest knowledge 
level on polycystic ovarian syndrome. The post test mean score (25.34) was high 
when compared to the pretest mean (11.92) score of knowledge. The obtained t value 
(44.7) was greater than table value at 0.05 level of significance,which shows that there 
is significant difference between pretest and posttest level of knowledge regarding 
polycystic ovarian syndrome among adolescent girls. Hence, the formulated research 
hypothesis H1 was accepted. 
S.NO Level of knowledge Mean 
Mean
difference
SD ‘t’ value 
1.
2.
Pretest 
Posttest 
11.92
25.34 13.42
2.6
1.87 44.7
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Figure 15: Distribution of adolescent girls according to their comparison 
of pre test and post testknowledge level
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SECTION – IV 
Association of pretest knowledge level of adolescent girl with their 
selected demographic variables 
Table 5-Association of knowledge level of adolescent girl with their selected 
demographic variables 
S.NO Demographic variables frequency
Chi square value 
ܠ૛
      1. Age 16-17
18-19
65
35
0.48
(NS)
2. Type of 
family 
Nuclear
Joint
85
15
6.34
(S)
3. Area of 
residence 
Rural
Urban
26
74
5.13
(s)
4. Previous
source of 
information 
Through
family 
Friends
Mass media 
No information 
0
4
4
92
5.87
(NS)
5. Body mass 
index
Low weight 
Normal 
Over weight 
Obesity 
27
66
7
0
2.12
(NS)
47
Table-5 depicts that the association of adolescent girl’s knowledge on 
polycystic ovarian syndrome with their age, the calculated value of chi-square (0.48) 
was less than the table value at 0.05 level of significance. So there was no significant 
association exist between the ages of polycystic ovarian syndrome with their 
knowledge
 The above table depicts the association of adolescent girl’s knowledge on 
polycystic ovarian syndrome with their type of family; the calculation value of chi-
square (6.34) was greater than the table value at 0.05 level significance. So there is a 
significant association exist between the type of family with their knowledge. 
The above table depicts the association of adolescent girl’s knowledge on 
polycystic ovarian syndrome with their area of residence; the calculated value of chi-
square (5.13) was greater than the table value at 0.05 level of significance. So there 
was significant association exist between the area of residence of adolescent girls with 
their knowledge 
The above table depicts the association of adolescents girls knowledge on 
polycystic ovarian syndrome with their previous source of information regarding 
polycystic ovarian syndrome, the calculation value of chi-square (5.87) was the lesser 
than the table value at 0.05 level of significance. So there is no significant association 
exist between the previous source of information regarding polycystic ovarian 
syndrome of adolescents girls with their pretest level of knowledge 
The above table depicts the association of adolescent girls knowledge on polycystic 
ovarian syndrome with their body mass index, the calculated value of chi-square 
(2.12) was lesser than the table value at 0.05 level of significance, so there is no 
significant association exist between the body mass indexes of adolescent girls with 
their knowledge.
CHAPTER- V 
DISCUSSION AND CONCLUSION 
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CHAPTER V 
DISCUSSION, SUMMARY, CONCLUSION, IMPLICATION, 
RECOMMENDATION. 
         Poly Cystic Ovarian Syndrome is a relatively common endocrine disorder in 
women of reproductive age group. It is found in around 70% of women who have 
ovulation difficulties leading to sub-fertility. Fertility problems experienced by 
women with Poly Cystic Ovarian Syndrome may be related to the elevated hormones 
(androgen and estrogen), insulin or glucose levels, all of which can interfere with 
implantation as well as development of the embryo. (Rizvi Javad-2015) 
Polycystic ovary syndrome (PCOS) is DFRQGLWLRQZKLFKFDQDIIHFWDZRPDQ¶V
menstrual cycle, fertility, hormones and aspects of her appearance. Polycystic ovaries 
are slightly larger than normal ovaries and have twice the number of follicles (small 
cysts). Polycystic ovaries are very common affecting 20 in 100 (20%) of women. 
(Royal college guidelines committee-2010) 
 
The aim of the present study was designed to evaluate the effectiveness of self 
instructional module on knowledge regarding polycystic ovarian syndrome among 
adolescent girls in selected college at sivagangai district. I selected 100 adolescent 
girls who were studying in the selected college at sivagangai district. Non probability 
sampling technique was used to derive the samples. 
 
  The first objective was to assess the pretest knowledge regarding 
polycystic ovarian syndrome among adolescent girls. 
 
    In this study,adolescent girls pretest knowledge score regarding polycystic 
ovarian syndrome was assessed. Majority (74%) of adolescent girls had inadequate 
knowledge and (26%) had moderate level knowledge. Nobody had adequate 
knowledge  in the pretest. 
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The second objective was to assess the effectiveness of self instructional 
module on knowledge regarding polycystic ovarian syndrome          
In the post test, Majority (92%) had adequate knowledge and only (8%) had 
moderate knowledge. The post test mean score (25.34) was high when compared to 
pre test mean (11.92) score of knowledge. The REWDLQHGµW¶ value (44.7) was greater 
than table value at 0.05 level of significance ,which shows there is a significant 
difference between the pretest and post test  knowledge of adolescent  girls. Hence, 
the formulated research hypotheses.H1 was accepted. This shows that there was a 
significant improvement in knowledge of adolescent girls regarding polycystic 
ovarian syndrome after administration of self instructional module, so the self 
instructional module was effective in improving knowledge of adolescent girls on 
polycystic ovarian syndrome. 
The third objective was to associate the pretest knowledge scores with 
their selected demographic variables. 
The present study reveals that there is a significant association between the 
pretest knowledge scores with their selected demographic variables. Regarding type 
of family, the obtained chi-square value was 6.34 at df (1) was significant at 0.05 
level. Regarding area of residence, the calculated chi-square was 5.13 at df (1) was 
significant at 0.05 level. Hence the formulated research hypothesis, H2 was accepted. 
The other demographic YDULDEOHVXFKDVDJH UHOLJLRQ0RWKHU¶VHGXFDWLRQVKRZV no 
association with pretest knowledge score. 
Summary: 
 The study was conducted to evaluate the effectiveness of self instructional 
module on knowledge regarding polycystic ovarian syndrome among adolescent girls 
in selected college at sivagangai district. 
 The objectives of the study were 
 To assess the pretest knowledge regarding polycystic ovarian syndrome among 
adolescent girls.  
 To evaluate the effectiveness of self-instructional module on knowledge 
regarding polycystic ovarian syndrome among adolescent girls. 
 To find out the association between the pretest knowledge regarding polycystic 
ovarian syndrome with their selected demographic variables. 
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The hypotheses of the study were 
  H1. : There is a significant difference between pretest and posttest knowledge 
regarding polycystic ovarian syndrome among adolescent girls. 
H2: There is a significant association between pretest knowledge with their 
selected demographic variables. 
        The first hypothesis shows significant difference between pretest and post 
test knowledge regarding polycystic ovarian syndrome. 
 Majority (74%) of adolescent girls had inadequate level of knowledge and 
(26%) had moderate level of knowledge. Nobody had adequate knowledge in the 
pretest .But in the post test  majority (92%) of adolescent girls had adequate 
knowledge and (8%) had moderate level of knowledge .The findings summarizes that 
the self instructional module has significant beneficial effect in the  knowledge among 
adolescent  girls. The post test mean score(25.34) was high  when compared to pretest 
mean score (11.92) 6FRUH RI NQRZOHGJH 7KH REWDLQHG µW¶ YDOXH ZDV JUHDWHU
than table values at 0.05 level of significance ,which shows there is a significant 
difference between pretest and post test  knowledge regarding polycystic ovarian 
syndrome among adolescent girls. Hence, the formulated research hypotheses  H1 was 
accepted. 
The second hypotheses show significant association between the 
knowledge score and selected demographic variables. 
The present study reveals that there is a significant association between the 
pretest scores 
With their selected demographic variables. Regarding type of family, the obtained 
chi-square value was 6.34 at df (1) was significant at 0.05 level. Regarding area of 
residence, the calculated chi-square was 5.13 at df (1) was significant at 0.05 level. 
Hence the formulated research hypothesis H2 was accepted. The other demographic 
variable such as age, religion, 0RWKHU¶VHGXFDWLRQVKRZVQRDVVRFLDWLRQZLWK pretest 
knowledge score. 
           The study tested and proved the hypotheses H1 that there is a significant 
improvement in the pre test and post test knowledge of adolescent girls who received 
self instructional module. H2  that there is a significant association exist between the 
pretest knowledge score with their selected demographic variables.  
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        The study was based on 6KXIIOH %HDP¶V &,33 3URJUDPPH (YDOXDWLRQ0RGHO
(1960); An evaluator approach used to conduct the study. The research design 
adopted for the present study was pre-experimental. Purposive random sampling 
technique was used for selection of samples. The data was collected for a period of 
two weeks from the adolescent girls in selected college at sivagangai. The investigator 
given self instructional module on poly cystic ovarian syndrome. Then they were 
assessed to test knowledge after a week with structured questionnaire. 
   Based on the objectives and hypotheses, the data were analysed using both 
descriptive and inferential statistics. 
Major findings of the study: 
x Out of 100 adolescents girls, with regards to age (65%) were 16 ± 17 years, 
(35%) were 18 ± 19 years. 
x Regards to religion, majority of the samples (86%) belongs to Hindu and 
(14%) were Christians and no Muslims. 
x 5HJDUGLQJPRWKHU¶V HGXFDWLRQDO VWDWXV (25%) were illiterate,(27%) had high 
school,(35%) were higher secondary school,(13%) were under graduate and 
no post graduate.    
x 5HJDUGLQJ WR PRWKHU¶V RFFXSDWLRQ PDMRULW\ RI WKH VDPSOHV  ZHUH
Housewife ,(28%) were private employee and no Government employee.  
x With regards to type of family (85%) were Nuclear and (15%) were Joint 
family.  
x Distribution of subjects with reference to Economic status (100%) were 
middle class and no lower class and upper class.  
x With regards to Area of Residence (26%) were rural and (74%) were Urban.  
x With regards to Source of information majority of the samples (92%) belongs 
to No previous information, and (4%) were from mass media,(4%) from 
friends. 
x Regarding Body mass index majority of samples (66%) belongs to normal, 
(27%) were low weight, (7%) belongs to overweight and no one belongs to 
obesity 
x Regarding Age at menarche (85%) belongs to 13 ± 15 yrs, (5%) belongs to 
below 13 years and no one in above 15 years 
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x Regarding duration of menstruation majority of the sample (82%) belongs to 3 
± 5 days. 
x Regarding interval between menstrual cycle (93%) belongs to 1 ± 2 
months,(7%) were below 1 month and no one belongs to above 2 month . 
x Regarding bleeding (67%) belongs to normal bleeding, (26%) mild bleeding, 
(7%) belongs to severe bleeding and no one belongs to no bleeding. 
x pre test knowledge score of adolescent girls on polycystic ovarian syndrome, 
(74%) of adolescent girls had inadequate level of knowledge and (26%) had 
moderate level of knowledge. Nobody had adequate knowledge in the pretest 
.But in the post test , majority (92%) of adolescent girls had adequate 
knowledge and (8%) had moderate level of knowledge . The post test mean 
score(25.34) was high  when compared to pretest mean score (11.92) of 
NQRZOHGJH7KHREWDLQHGµW¶YDOXHZDVJUHDWHUWKDQWDEOHYDOXHVDW
level of significance ,which shows there is a significant difference between 
pretest and post test knowledge regarding polycystic ovarian syndrome among 
adolescent girls. Hence ,the formulated research hypotheses H1 was accepted. 
This shows that there was significant improvement in knowledge score on 
polycystic ovarian syndrome after administering self instructional module. 
x Study reveals that there is a significant association between the pre test 
knowledge score with their selected demographic variables. Regarding type of 
family, the obtained chi-square value was 6.34 at df (1) was significant at 0.05 
level.Rregarding  area of residence  the calculated chi-square was 5.13 at df 
(1) was significant at 0.05 level. Hence the formulated research hypotheses H2  
was accepted. The other demographic variables such as age, religion, 
0RWKHU¶VHGXFDWLRQVKRZVQRDVVRFLDWLRQZLWK pretest  knowledge score. 
 Conclusion :  
                 The above study depicts that, the obtained value was greater than the table 
value which shows significant improvement in knowledge of adolescent girls. Hence 
the self instructional module was effective. 
 Implications: 
 The present study findings have several implications in hospital settings, nursing 
practice, nursing education, nursing research, and nursing administration. 
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 Nursing practice: 
x Nurse owes a great responsibility in educating the people regarding polycystic 
ovarian syndrome. 
  Nursing Education: 
x Self instructional module can be used by the student to imparting knowledge 
on polycystic ovarian to the adolescent girls in both urban and rural while 
giving health education. 
x Nurse educator can prepare the nursing students in order to give importance of 
teaching programme on polycystic ovarian syndrome by using different 
educational and teaching aids. 
Nursing research: 
     The findings of the present study are helpful for the nursing professionals and 
nursing teachers to conduct further studies to find out the effectiveness of various 
methods of providing education on improving the knowledge regarding polycystic 
ovarian syndrome.  
Nursing administration: 
x Nurse administrator should take interest in motivating the nursing personnel to 
improve their professional knowledge and skill by attending the workshops, 
conferences, seminars on polycystic ovarian syndrome. 
x Nurse administrator should arrange regular in service education program to the 
health care workers for gaining knowledge. 
Recommendations : 
x A comparative study may be conducted to evaluate the effectiveness of self 
instructional module. 
x A similar study can be conducted on large sample to assess the knowledge and 
attitude regarding polycystic ovarian syndrome. 
x A study can be conducted in assessing knowledge and practice of polycystic 
ovarian syndrome. 
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APPENDIX I 
RESEARCH TOOL 
Effectiveness of Self Instructional Module (SIM) on knowledge regarding 
polycystic ovarian syndrome (PCOS) among adolescent girls in selected college 
at Sivagangai 
SECTION - A 
DEMOGRAPHIC DATA 
    SAMPLE NO: 
SECTION: A 
1. Age in years 
a) 16-17 years 
b) 18-19 years 
2. Religion 
a) Hindu 
b) Christian 
c) Muslim 
3. Mother¶s educational qualification 
a) Illiterate 
b) Primary 
c) Secondary 
d) Undergraduate 
e) Postgraduate 
4. MoWKHU¶V occupation 
a) House wife 
b) Private employee 
c) Government employee 
5. Type of family 
a) Nuclear 
b) Joint 
6. Socio economic status 
a) Lower class family 
b) Middle  class family 
c) Upper  class family 
7. Area of residence 
a) Rural 
b) Urban 
 
8. Source of previous information regarding polycystic ovarian syndrome? 
a) Through family members 
b) Through friends 
c) Mass media 
d) no information 
MEASUREMENTS: 
1. Height      ----------------- 
2. Weight     ----------------- 
MENSTRUAL DATA: 
1. Age at menarche                  ------------------------ 
2. Duration of menstruation     ------------------------ 
3. Frequency of menstruation  ------------------------ 
4. Menstrual bleeding: 
                       a)Normal bleeding 
                       b)Absence of bleeding 
c)Mild  bleeding 
                       d)Severe bleeding 
SECTION: B -  SEMI STRUCTURED QUESTIONNIARE: 
Instruction : please read the following questions and tick  the answer  
in the appropriate options 
1. Where are the ovaries  situated in female reproductive system? 
a) Inside the uterus 
b) Each side of the uterus 
c) Below the uterus 
d) Above the uterus 
2. How many ovaries are present in female reproductive system? 
a) 2
b) 4
c) 1
d) 3
3. What is the shape of the ovaries? 
a) Diamond 
b) Square
c) round
d) almond 
4. What are the two types of cells present in the ovaries? 
a) Stroma cells and squamous cells 
b) Stratified cells and columnar cells 
c) Granulosa cells and theca cells 
d) Epithelial cells and endothelial cells 
5. Which female hormones  are produced by ovaries? 
a) Estrogen and progesterone 
b) Testosterone
c) Prolactin 
d) thyroid
6. What is polycystic ovarian syndrome (PCOS)?  
a) Excessive androgen without enlarged polycystic ovaries 
b) Excessive androgen with hirsutism,amenorrhoea,obesity and 
enlarged polycystic ovaries
c) Excessive thyroxin with amenorrhoea 
d) Excessive prolactin with obesity 
7. Which age group people are mostly affected by polycystic ovarian syndrome? 
a) Pre puberty 
b) Postmenopausal 
c) Adolescent
d) Old age 
8. Who are all at risk people for develops polycystic ovarian syndrome? 
a) Family history of seizure 
b) Family history of diabetes 
c) Family history of cardiovascular disease 
d) Family history of night blindness 
9. Which is the hormone responsible for develops polycystic ovarian syndrome? 
a) Thyroxin and estrogen
b) Epinephrine and estrogen 
c) Estrogen and catecholamine 
d) Estrogen and testosterone 
10. What is the cause of polycystic ovarian syndrome? 
a) Alteration in hypothalamus pituitary function 
b) Alteration in thyroid function 
c) Alteration in renal function 
d) Alteration in adrenal gland 
11. What is hyperinsulinemia? 
a) Increased level of glucagon in blood 
b) Increased level of thyroxin in blood 
c) Increased level of insulin in blood 
d) Increased level of adrenaline in blood 
12. Which enzyme is released by ovarian follicles due to hyperinsulinemia in 
polycystic ovarian syndrome? 
a) Peptidase 
b) Leptin 
c) Aromatase 
d) peptin
13. Which enzyme is essential for converting androgen to estrogen? 
a) Glucagon
b) Insulin 
c) Aromatase 
d) Leptin  
14. Which is the protein essential to bind with testosterone and estrogen in blood? 
a) Sex hormone binding globulin 
b) Somatic hormone binding globulin 
c) Estrogen hormone binding globulin 
d) Testosterone hormone binding globulin 
15. How the hyper estrogenic (increased estrogen level) stage will occur? 
a) Increased aromatization of progesterone 
b) Increased aromatization of estrogen 
c) Increased aromatization of androgen 
d) Increased aromatization of prolactin 
16. What is Hirsutism? 
a) Excessive nail growth 
b) Excessive hair growth 
c) Excessive muscle growth 
d) Excessive skin growth 
17. Where is the location of Acanthosis Nigrians in polycystic ovarian syndrome? 
a) Leg
b) Face
c) Neck
d) Eye
18. How many menstrual cycles occur in polycystic ovarian syndrome patient per 
year?
a) Less than 6 cycles per year 
b) Less  than 10 years per year 
c) Less than 8 cycle per year 
d) Less than 2 cycle per year 
19. How to identify polycystic ovarian syndrome through blood test? 
a) Hemoglobin test 
b) Liver function test 
c) Renal function test 
d) Hormone test 
20. Which is the major diagnostic tool for polycystic ovarian syndrome? 
a) Ultrasound for abdomen and uterus 
b) Echo
c) X ray 
d) Doppler scan 
21. What is the first line treatment for polycystic ovarian syndrome? 
a) Surgery
b)  exercise 
c) Diet and exercise 
d) Medication
22. What type of diet should be taken for polycystic ovarian syndrome? 
a) Fried food items 
b) Fiber and protein rich diet 
c) Fat rich diet 
d) Carbohydrate rich diet 
23. What type of diet should be avoided for polycystic ovarian syndrome? 
a) Fat
b) Protein
c) Unsaturated oils 
d) Fiber
24. What is the salt requirement per day in polycystic ovarian syndrome patient? 
a) Less than 2600 mg per day 
b) Less  than 2000 mg per day 
c) Less than 2200 mg per day 
d) Less than 2400 mg per day 
25. What is to be used instead of salt in dietary management of polycystic ovarian 
syndrome patient? 
a) Iodine salt 
b) Lemon  
c) Honey
d) Sauces 
26. What are the drugs used to correct irregular menstruation in polycystic ovarian 
syndrome? 
a) Metformin  
b) Contraceptive pills 
c) Progesterone tablets
d) All the above  
27. Which cream is used for unwanted hair growth in polycystic ovarian 
syndrome? 
a) Progesterone
b) Flutamide  
c) Eflorthine
d) Ranitidine  
28. What are the drugs used to treat infertility in polycystic ovarian syndrome? 
a) Clomifene,metformin,gonodotrphins 
b) Clomifene with metformin 
c) Clomifene 
d) gonodotrophins
29. What is the surgical treatment for polycystic ovarian syndrome? 
a) Resection of ovary 
b) Hysterectomy
c) Thyroidectomy
d) Ovarian diathermy 
30. What is the complication of polycystic ovarian syndrome? 
a) Carcinoma in liver  
b) Carcinoma in uterus 
c) Carcinoma in abdomen 
d) Carcinoma in pelvis 
APPENDIX – II 
ãÇî – m 
nghJg;Gs;sp tptug;gl;bay; 
1.  taJ 
m) 16ypUe;J 17 tiu 
   M) 18ypUe;J 19 tiu 
2.  kjk; 
m) ,e;J 
   M) fpwp];bad; 
   ,) K];yPk; 
3.  jhapd; fy;tpj; jFjp 
   m) gbf;ftpy;iy 
   M) mbg;gilf;fy;tp 
   ,) cah;epiyf;fy;tp 
   <) gl;lg;gbg;G 
   c) KJfiygl;lk; 
4.  jhapd; njhopy; 
m) ,y;yj;jurp 
   M) jdpahh; Copah; 
   ,) murhq;f Copah;;
5.  FLk;gj;jpd; tif 
m) jdpf;FLk;gk; 
   M) $l;Lf;FLk;gk; 
6.  nghUshjhu epiyik
   m) fPo;epiy 
   M) eLepiy 
,) cah;epiy
7.  FbapUg;G 
m) fpuhkk; 
   M) efuk; 
8.  vjd; %ykhf mz;lf ePh;f;fl;b Nehapid mwpe;J nfhz;Bh;fs; 
m) FLk;g egh;fs; 
   M) ez;gh;fs; 
   ,) njhopy; El;gk; 
   <) nra;jp mwpatpy;iy 
cly; msTfs; 
1. cauk; ______
2. vil _______
khjtplha; gw;wpa jfty;fs;: 
1.  g+g;gile;j taJ      ________
2.  khjtplhapd; fhy msT                _________
3. khjtplha; Row;rpf;F ,ilg;gl;l fhy msT  _______
4. khjtplha; ,uj;jNghf;F 
    m) rhpahd msT 
    M) khjtplhapd;ik 
    ,) Fiwe;j msT 
    <) mjpf msT 
ãÇî - M 
mz;lf ePh;f;fl;b Neha; gw;wpa mwptpid Nrhjpj;J mwpAk; 
tpdhtpilfs; 
1. ngz;zpd; ,dg;ngUf;f cWg;ghfpa mz;lfq;fs; vq;Nf 
mike;Js;sJ? 
  m) fh;g;gigapd; cs;Ns 
  M) fh;g;gigapd; ,UGwj;jpYk; 
  ,) fh;g;gigf;F fPo; 
  <) fh;g;gigf;F Nky; 
2. ngz;zpd; ,dg;ngUf;f cWg;gpy; vj;jid mz;lfq;fs; cs;sd? 
  m) 2 
  M) 4 
  ,) 1 
  <) 3 
3. ngz;zpd; ,dg;ngUf;f cWg;ghfpa mz;lfq;fspd; tbtk; vd;d? 
  m) itu tbtk; 
  M) rJuk; 
  ,) tl;lk; 
  <)  ghjhk; gUg;G Nghd;w tbtk; 
4. mz;lfq;fspy; fhzg;gLk; ,uz;L tifahd nry;fs; vd;d? 
  m) ];BNuhkh kw;Wk; ];Fthk]; nry;fs; 
  M) ];l;uhgpigL kw;Wk; fhYk;dhh; nry;fs; 
  ,) fpuhDNyhrh kw;Wk; jPfh nry;fs; 
  <) vgpjPypay; kw;Wk; vz;NlhjPypay; nry;fs; 
5. mz;lfq;fspdhy; Ruf;fg;gLk; ngz; ,d `hh;Nkhd; vJ? 
  m) <];l;Nuh[d; kw;Wk; g;Nuhn[];buhd; 
  M) nl];Nlh];lPuhd;
  ,) g;Nuhyhf;bd; 
  <) ijuhf;rpd; 
6. mz;lf ePh;f;fl;b Neha; vd;why; vd;d? 
  m) mjpf msT Md;l;Nuh[d; kw;Wk; tPf;fkw;w ePh;f;fl;bfis nfhz;l    
     mz;lfk; 
  M) mjpf msT Md;Nuh[Dld; `ph;Rbrk;> khjtplhapd;ik kw;Wk;  
     cly;gUkd;> tPf;fKs;s ePh;f;fl;bfis nfhz;l mz;lfk; 
  ,) mjpf msT ijuhf;rpDld; khjtplhapd;ik 
  <) mjpf msT g;Nuhyhf;bDld; cly; gUkd; 
7. mz;lf ePh;f;fl;b Nehapdhy; ve;j taJs;s ngz;fs; mjpfkhf    
  ghjpf;fg;gLfpd;wdh;? 
  m) gUtk; miltjw;F Kd; 
  M) khjtplha; Row;rp Kw;W ngw;w ngz;fs; 
  ,) gUt tajpy; cs;s ,sk;ngz;fs; 
  <) tajhd ngz;fs;  
8. mz;lf ePh;f;fl;b Neha; mjpfkhf ahUf;F tuyhk;? 
  m) guk;giu typg;G Neha; 
  M) guk;giu rh;f;fiu tpahjp 
  ,) guk;giu ,jak; rk;ke;jg;gl;l Neha;fs; 
  <) guk;giu khiyf;fz; Neha; 
9. ve;j `hh;Nkhdpd; msT mjpfhpg;gjhy; mz;lf ePh;f;fl;b Neha; 
Vw;gLk;?
  m) ijuhf;rpd; kw;Wk; <];l;Nuh[d; 
  M) <];l;Nuh[d; kw;Wk; vgpneg;hpd; 
  ,) <];l;Nuh[d; kw;Wk; fhyikd; 
  <) <];l;Nuh[d; kw;Wk; Md;l;Nuh[d;; 
10. mz;lf ePh;f;fl;b Nehapd; fhuzp vd;d? 
  m) i`Nghjyhk]; - gpl;ba+l;lhpd; nray;ghLfspy; khw;wq;fs; 
  M) ijuha;L nray;ghLfspy; khw;wq;fs; 
  ,) rPWePuf nray;ghLfspy; khw;wq;fs; 
  <) ml;hpdypd; nray;ghLfspy; khw;wq;fs; 
11. i`gh;,d;RypdPkpah vd;why; vd;d? 
   m) ,uj;jj;jpy; FSf;N;fhfhd; msT mjpfhpj;jy; 
   M) ,uj;jj;jpy; ijuhf;rpd; msT mjpfhpj;jy; 
   ,) ,uj;jj;jpy; ,d;Rypd; msT mjpfhpj;jy; 
   <) ,uj;jj;jpy; ml;hpdypd; msT mjpfhpj;jy; 
12. mz;lfePh;f;fl;b Nehapy; mjpf msT ,d;Rypdhy; mz;lfq;fspy; 
,Ue;J ntsptUk; vd;irk; vJ? 
   m) ngg;bNl]; 
   M) nyg;bd; 
   ,) mukNl]; 
   <) ngg;bd; 
13. Md;Nlhu[id <];l;Nuh[dhf khw;Wtjw;F Njitg;gLk; vd;irk; 
vJ?
   m) FSf`hd; 
   M) ,d;Rypd; 
   ,) mukNl]; 
   <) nyg;bd; 
14. ,uj;jj;jpy; nl];Nlh];BuhidAk;> <];l;Nuh[idAk; gpidf;f 
Njitg;gLk;  Gujk; vJ? 
   m) nrf;]; `hh;Nkhd; igd;bq; FNshGypd; 
   M) nrhkhbf; `hh;Nkhd; igd;bq; FNshGypd; 
   ,) <];l;Nuh[d; `hh;Nkhd; igd;bq; FNshGypd; 
   <) nl];Nlh];Buhd; igd;bq; FNshGypd; 
15. vjdhy; <];l;Nuh[d; msT mjpfkhfpwJ? 
   m) g;Nuhn[];buhd; mjpfhpg;gjhy; 
   M) <];l;Nuh[d; mjpfhpg;gjhy; 
   ,) Md;l;Nuh[d; mjpfhpg;gjhy; 
   <) g;nuhyhf;bd; mjpfhpg;gjhy; 
16. `ph;Rbrk; vd;why; vd;d? 
   m) mjpfkhd Nuhk tsh;r;rp 
   M) mjpfkhd efk; tsh;r;rp 
   ,) mjpfkhd jir tsh;r;rp 
   <) mjpfkhd Njhy; tsh;r;rp 
17. mz;lf ePh;f;fl;b Neha; cs;sth;fSf;F vfhd;Njhrp]; ief;hpad;]; 
vq;Nf fhzg;gLk;? 
   m) fhy; 
   M) Kfk; 
   ,) fOj;J 
   <) fz; 
18. mz;lf ePh;f;fl;b Neha; cs;sth;fSf;F xUtUlj;jpy; vj;jid 
Kiw khjtplha; Row;rp Vw;gLk;? 
   m) 8f;F Fiwthf 
   M) 6f;F Fiwthf 
   ,) 2f;F Fiwthf 
   <) 10f;F Fiwthf 
19. ,uj;jj;jpy; mz;lf ePh;f;fl;b Nehapid vt;thW fz;lwpayhk;? 
   m) `pNkhFNshgpd; Nrhjid 
   M) fy;yPuy; nray;ghL Nrhjid 
   ,) rpWePuf Nrhjid 
   <) `hh;Nkhd; Nrhjid 
20. mz;lf ePh;f;fl;b Nehapid fz;lwpAk; Kf;fpakhd Nrhjid vd;d? 
   m) tapW kw;Wk; fh;g;gig my;l;uhrTz;l; ];Nfd; 
   M) v/Nfh 
   ,) vf;];Nu 
   <) lhg;yh; ];Nfd; 
21. mz;lf ePh;f;fl;b Neha;f;F vJ Kjd;ikahd rpfpr;ir Kiw? 
   m) mWit rpfpr;ir 
   M) clw;gapw;rp 
   ,) czT tiffs; kw;Wk; clw;gapw;rp 
   <) khj;jpiufs; 
22. mz;lf ePh;f;fl;b Neha;f;F ve;j tifahd czTg;nghUl;fis 
vLj;J nfhs;s Ntz;Lk;? 
   m) tWf;fg;gl;l czTg;nghUl;fs;
   M) Gujk; kw;Wk; ehh;rj;J czTg; nghUl;s; 
   ,) nfhOg;G rj;J epiwe;j czTg;nghUl;fs; 
   <) fhh;Nghi`l;Nul; epiwe;j czTg; nghUl;fs; 
23. mz;lf ePh;f;fl;b Neha;f;F ve;j tifahd czTg;nghUl;fis 
jtph;f;f Ntz;Lk;? 
   m) nfhOg;G rj;J epiwe;j czTg; nghUl;fs; 
   M) Gujk; rj;J epiwe;j czTg;nghUl;fs; 
   ,) nrwpt+l;lg;glhj vz;nza;fs; 
   <) ehh;rj;J epiwe;j czTg;nghUl;fs; 
24. mz;lfePh;f;fl;b Neha; cs;sth;fs; xU ehisf;F vt;tsT cg;G 
Nrh;j;J nfhs;s Ntz;Lk;? 
   m) 2600 msTf;F Fiwthf 
   M) 2000 msTf;F Fiwthf 
   ,) 2200 msTf;F Fiwthf 
   <) 2400 msTf;F Fiwthf 
25. mz;lfePh;f;fl;b Neha;f;F cztpy; cg;gpw;F gjpyhf vij Nrh;j;J 
nfhs;s Ntz;L;k;? 
   m) mNahbd; cg;G 
   M) vYkpr;ir 
   ,) Njd; 
   <) rh]; 
26. mz;lf ePh;f;fl;b Nehapdhy; Vw;gLk; xOq;fw;w khjtplha; Row;rpf;F 
ve;j khj;jpiuia vLj;J nfhs;s Ntz;Lk;? 
   m) nkl;ghu;hpkpd; 
   M) fUj;jil khj;jpiufs; 
   ,) g;Nuhn[];buhd; khj;jpiufs; 
   <) ,it midj;Jk; 
27. mz;lf ePh;f;fl;b Nehapdhy; Vw;gLk; Njitaw;w Nuhk tsh;r;rpf;F 
ve;j fphpik gad;gLj;j Ntz;Lk;? 
   m) /g;Nuhn[];buhd; 
   M) /GSlikL 
   ,) v/NghNyhh;jPd; 
   <) uhdpbbd; 
28. mz;lf ePh;f;fl;b Nehapdhy; Vw;gLk; fUTWjy; gpur;ridfSf;F 
ve;j khj;jpiuia vLj;J nfhs;s Ntz;Lk;? 
   m) FNshkpNgd;> nkl;ghu;kpd; kw;Wk; FNdhNlhl;Nuhgpd; 
   M) FNshkpNgDld; nkl;ghh;kpd; 
   ,) FNshkpNgd; 
   <) FNdhNlhl;Nuhgpd; 
29. mz;lf ePh;f;fl;b Neha;f;F nra;Ak; mWitrpfpr;ir vd;d? 
   m) mz;lfj;ij ePf;Fjy; 
   M) ijuha;il ePf;Fjy; 
   ,) fh;g;gigia ePf;Fjy; 
   <) XNthpad; ilanjh;kp 
30. mz;lf ePh;f;fl;b Nehapdhy; Vw;gLk; tpisT vJ? 
   m) fy;yPuy; Gw;WNeha; 
   M) fh;g;gig Gw;WNeha; 
   ,) tapw;wpy; Gw;WNeha; 
   <) ,Lg;ngYk;gpy; Gw;WNeha; 
APPENDIX - IV 
ANSWER KEY 
Answer key and score for the  knowledge questionnaire to assess the knowledge regarding 
polycystic ovarian syndrome. 
 
SL.NO ANSWER 
KEY 
SCORE 
1 b 1 
2 a 1 
3 d 1 
4 c 1 
5 a 1 
6 b 1 
7 c 1 
8 b 1 
9 d 1 
10 a 1 
11 c 1 
12 b 1 
13 c 1 
14 a 1 
15 c 1 
16 b 1 
17 c 1 
18 c 1 
19 d 1 
20 a 1 
21 c 1 
22 b 1 
23 a 1 
24 a 1 
25 b 1 
26 d 1 
27 c 1 
28 a 1 
29 d 1 
30 b 1 
 
Polycystic Ovarian Syndrome (PCOS) and its management 
Introduction: 
Polycystic ovarian syndrome (pcos) is a common 
condition in reproductive age group. It is an  hormone 
disorder among women of reproductive age and it is the 
leading cause of infertility.
Anatomy of Ovaries: 
1. In female reproductive system the ovaries are two in number, situated one on each 
side of the uterus which is present deep in a women’s pelvis.
2. The ovaries are situated close to the end of the fallopian 
tubes. 
3. The ovaries are almond shaped and about 3.5 cm long, 
2cm wide, 1.5 cm thick and it weighs 4-8 grams 
4. In each ovaries 5-7 ovarian follicles are present and it 
measures 2 mm 
5. Granulose cells and theca calls are present in ovaries 
Function of Ovaries: 
1. Every month they produce mature eggs for 
menstruation and fertilization. 
2. They produce female hormones(estrogen and 
progesterone) and lesser amount of male hormones 
(androgen) 
Ovulation: 
    Mature egg (ovum) released from ovary. It is essential for  menstruation and 
fertilization
Normal values of hormones: 
Luitenising hormone 5-25 IU/l 
Follicle stimulating hormone 4.7-21.5 MIU/ml 
Testosterone 15-70 ng/dl 
Sex hormone binding globulin 18-144 nmol/2 
Estrogen 15-350 mg/ml 
Insulin 40-50 units 
   
Definition of Polycystic Ovarian Syndrome (PCOS) 
 Polycystic ovarian syndrome (pcos) is a heterogenous disorder characterized 
by excessive androgen production by the ovaries, which interferes with the 
reproductive, endocrine and metabolic functions manifested by amenorrhoea, 
hirsutism, and obesity associated with enlarged polycystic ovaries.  
Incidence: 
1. 5 – 10 % women of reproductive age group (14-45 years) are affected
2. In India 2.2 – 26 % women of reproductive age group are affected in 
Mostly adolescent groups (16-19 years ) are affected.
Risk Factors: 
1. Physical inactivity
2. Sedentary life style   
3. Family history of Polycystic ovarian 
syndrome 
4. Family history of diabetes 
Causes:  
1. obesity and insulin resistance:
     obesity will leads to insulin resistance . 
increased insulin will stimulate ovaries to 
produce excess amount of 
androgen(testosterone)  
2. Alteration in hypothalamic-pituitary function: 
    It leads to imbalance of follicle stimulating 
hormone and luitenising hormone, that affect normal 
ovulation and produce excess amount of estrogen 
3. Hyperandrogenism (increase level of androgen) 
    Hyperandrogenism produce excess amount of estrogen and affect normal 
ovuvlation. 
Normal Hormone Regulation:
Brain
FSH     LH;        
      
ovary
Blood
Hypothalamus (brain)
Gonodotrophin releasing hormone 
Anterior pituitary hormone
Granulosa cells                Theca cells
(aromatase 
              converts)          
Oocyte                                              androgen    development        
(androstedione)
estrogen 
Sex hormone binding globulin combined with estrogen and 
testosterone to maintain its functions 
Pathophysiology of   Polycystic ovarian syndrome:
 FSH                           LH
(follicle stimulating hormone)      (Luiteniring hormone) is  increasing                        
is not  increasing 
         
        
Induce aromatisation        [Decrease sex hormone binding o     
F                       o of androgen                         globulin ,it binds With testosterone   and                       
estrogen to                               estrogen to  maintain normal function ] 
    Hyper estrogenic state ( increased estrogen level) 
Menstrual disturbances (absence of bleeding,irregular bleeding) 
    Hypothalamus (brain) 
         In hyperinsulinemia( increase level of insulin) stage leptin released by 
ovarian follicles      
     Increase Gonodotrophin releasing hormone 
     Anterior pituitary hormone
Theca cells 
Androgen (releasing 
testosterone 
Signs and Symptoms:
1. Menstrual Irregularity 
• Less than 8 menstrualcycle per year 
• Severe bleeding ( menorrhagia) 
• Mild bleeding (hypo menorrhea) 
• Absence of menstruation ( amenorrhoea) 
• Infrequent menstruation  ( oligomenorrhoea) 
2. Weight gain
3. Acne
4. Hirsutism:
Hair growth on upper lip, chin, neck, 
chest,upper and lower abdomen, back 
5. Male-pattern baldness
6. Enlargement of clitoris 
7. Acanthosis nigrians 
   Dark or thick skin marking and creases around 
the arm,groin,neck 
Diagnostic test:
1. History: 
• Details of history of diabetes 
• Questions about symptom like weight gain menstrual 
cycle etc 
2. Blood test:
 To check glucose level and hormone levels 
• Testosterone levels greater then 70 ng/dl indicate 
pcos. 
• LH exceed more than 25 iu/l indicates pcos. 
• Sex hormone binding globulin less than 144 nmol/2 indicates pcos. 
• Insulin excess 40-50  units indicates insulin resistance. 
3. Ultra sound for abdomen @ uterus:
       It is the major diagnostic tool, which  show 
enlarged ovaries with small cysts.
Management:
1. Lifestyle modification
2. Medical treatment
3. Surgical treatment
1. Lifestyle modifications: (first line treatment) 
It is the first line treatment. Polycystic ovarian syndrome can be greatly 
improved by losing excess weight. losing excess weight by healthy balance 
diet and exercise
                           BMI 
        <18.5            – Under weight 
                   18.5 – 24.9   - normal  
                   25 – 29.9      - over weight 
                   >30               - obesity 
FOOD ITEMS TO BE TAKEN EXAMPLES 
1. Consume food in their most nature form 
(fresh)
Fruits
Vegetables
2. Introduce fiber gradually 
     3. Consume Protein diet 
 Nuts 
Cabbage  
Soyabeans 
Apple 
seeds 
Fish
FOODS TO BE REDUCED EXAMPLES 
1. Consume low fat or fat 
free dairy products: 
2. Food which contain sugar 
should be reduced: 
3 Food which contain 
Carbohydrate should be 
reduced  
4 Limit salt intake 
Use for 
unsaturated oils 
(corn oils) 
Sweets 
Use jaggeri instead 
of sugar 
Rice (1 time / day) 
Consume less than 
2400 mg of salt per 
day
Use Lemon, Pepper 
instead of salt 
Recommended life style changes: 
1. Weigh loss of 5 – 10% 
2. Decreased calorie intake 
3. Increased fiber intake 
4. Decreased fat intake 
5. Small, frequent diet (every day 4 – 5 times) 
6. Balanced meals with CHO, protein, fat 
Exercise: 
1. Regular exercise.30 min / day. Slowly the time has to be 
increased. 
2. Involved in house hold activities
PROBLEMS        TREATMENT USES
 Irregular 
menstruation 
Infertility 
problems 
 Hormone 
tablets 
(progestin)
Metformin
1.;clomifene with 
metformin 
2.gonodotrophin
s
.(pregnel)
These all inhibit 
effect on hypothalamic 
release of GNRH and 
maintain normal level 
of FSH and LH to 
promote normal 
ovulation.
It prevent insulin 
resistance  by making 
the body to response 
insulin effectively 
Gonodotrophins are 
stimulate follicle 
stimulating hormone 
and maintain ovulation 
Unwanted hair 
growth 
Acne  
Surgical 
treatment 
Combined hormone pills (dianette)
(eflorithine 
cream) 
;(flutamide) 
(spiranolactone) 
Wash your face daily 
.don’t over wash 
Avoids food that are 
high in sugar,fat. 
Shaving
Laser 
ovarian diathermy-
laparoscopic ovarian 
drilling 
These all works by 
blocking the effect of male 
hormone (testosterone) 
 Use physical removing for 
excess hair 
Under GA through 
laparoscope, the ovaries 
are surgically treated by 
using heat or laser to 
destroy the tissues that 
producing male hormone 
(testosterone) and restore 
normal function. 
Complications:
Type II diabetes 
Infertility  
Carcinoma in uterus 
High blood pressure 
    mz;lf ePh;f;fl;b Neha; kw;Wk; mjd; 
    rpfpr;ir Kiwfs;
Kd;Diu:
    mz;lf ePh;f;fl;b Neha; vd;gJ ,dg;ngUf;f 
taJs;s (15-45 taJ) ngz;fSf;F>%isapy; cs;s 
gpl;ba+l;;lhp kw;Wk; mz;lfr;Rug;gpapy;  Ruf;Fk; 
`hh;Nkhd;fspd; FiwghLfspdhy; Vw;gLk; xU 
nghJthd Neha; MFk;. ,J Foe;ijapd;ik Vw;gl 
Kf;fpa fhuzpahf mikfpwJ.
mz;lfj;jpd; mikg;G: 
1. ngz;zpd; ,dg;ngUf;f cWg;gpy; nkhj;jk; ,uz;L 
mz;lfq;fs; cs;sd. 
2. mz;lfq;fs; fh;g;gigapd; ,UGwj;jpy; cs;s 
fUKl;il Fohapd; Kbtpy; neUf;fkhf 
mike;Js;sd. 
3. mz;lfq;fs; ghjhk; gUg;G tbtj;jpy; ,Uf;fpd;wd  
kw;Wk; ,jd; ePsk; 3..5 nrkP. mfyk; 2 nr.kP> mlh;j;jp 1.5 nr.kP vdil 4-8 
fpuhk;.
4. xt;nthU mz;lfj;jpYk; 5-7 tiu rpwpa ePH;f;Fkpopfs; fhzg;gLk;. ,jd; 
msT 2mm
5. fpuhDNyhrh kw;Wk; jPfh vd;w ,uz;L tifahd nry;fs; mz;lfj;jpy; 
fhzg;gLfpd;wd. 
mz;lfq;fspd; nray;ghLfs;:
1. xt;nthU khjKk; mz;lfq;fs;> khjtplha; Row;rp kw;Wk; fUTWjYf;F 
Njitahd Kjph;e;j Kl;ilfis cUthf;FfpwJ. 
2. mz;lfq;fs; ngz; ,d `hh;Nkhd;fshd 
(<];l;Nuh[d; kw;Wk; g;Nuhn[];buhd;) kw;Wk; Mz; 
,d `hh;Nkhdhd (Mz;l;Nuh[d; rpwpa mstpy; ) 
cw;gj;jp nra;fpwJ. 
3. mz;lk; ntspNaWjy; 
  mz;lfj;jpypUe;J Kjph;e;j Kl;il (mz;lk;)    
ntspNaWfpwJ. khjtplha; Row;rp kw;Wk; 
fUTWjYf;F mz;lk; kpfTk; Kf;fpakhdJ. 
`hh;Nkhd;fspd; rhpahd msTfs;: 
1.Ybidrpq; `hh;Nkhd; - 5-25 IU/L 
2./ghypf;fpy; ;];LKNybq; 
`hh;Nkhd; 
- 4.7-21.5 MIU/L
3.nl];Nlh];Buhd; - 15-70 ng/dl 
4.nrf;];` hh;Nkhd;igd;bq; 
FNshGspd;
- 18-144 nmol/2 
5.<];l;Nuh[d; - 15-350 mg/ml 
7.,d;Rypd;  - 40-50 units 
   
mz;lfePH;f;fl;b Nehapd; tiuaiw:
mz;lf ePh;f;fl;b Neha; vd;gJ gy ePh;f;fl;bfis nfhz;l tPf;fKs;s 
mz;lfk; MFk;.,e;Neha; ngz;fSf;F Mz;l;Nuh[d; `hh;Nkhd; mjpf mstpy; 
Rug;gjpdhy; Vw;gLfpwJ. ,jdhy; khjtplhapd;ik> cly; gUkd; mjpfhpj;jy; 
kw;Wk; `ph;Rbrk;> vdg;gLk; Njitaw;w Nuhk  tsh;r;rp clypd; gy gFjpfspy; 
Vw;g;gLk;.
epfo;Tfs;: 
1. cyfstpy; mz;lf ePH;f;fl;b Neha;f;F ,dg;ngUf;f taJs;s   (15-
45taJ) ngz;fs; 5-10% ghjpf;fg;gLfpd;wdh;. 
2. ,e;jpahtpy; kl;Lk; 22-26% ,dg;ngUf;f taJs;s 
 (15-45 taJ) ngz;fs; ghjpf;fg;gLfpd;wdh;  
ngUk;ghYk; ,sk; taJ ngz;fs; (16-19 taJ) mjpfkhf  ghjpf;fg;gLfpd;wdh; 
Mgj;J fhuzpfs;:
1.cly; ciog;gpd;ik
2. ke;jkhd tho;f;if Kiw 
3. guk;giu mz;lf ePH;f;fl;b Neha; 
4. guk;giu rh;f;fiu tpahjp 
fhuzq;fs;: 
1. cly; gUkd; kw;Wk; ,d;Rypd;  vjph;g;G: 
   cly;gUkd; mjpfhpg;gjhy; ,d;Rypd; vjph;g;G 
Vw;gLfpwJ. ,t;tpisT, mz;lfj;ij mjpf mstpy; 
Mz; ,d `hh;Nkhdhfpa Mz;;l;Nuh[d;; 
(nl];Nlh];Buhd;) Ruf;f Jz;LfpwJ. 
2. i`Nghjyhk]; - gpl;ba+l;lhp nray;fspd; 
khWghLfs;: 
         ,k;khWghLfspdhy;  /ghypf;fpy;  ];LKNyl;bq; 
`hh;Nkhd; kw;Wk; Ybidrpq; `hh;Nkhd;fspy; 
rkepiyapd;ik Vw;gLfpwJ. ,r;rkepiyapd;ikahdJ,
mz;lfj;jpypUe;J mjpfg;gbahd <];l;Nuh[d; Ruf;f 
toptFf;fpwJ.. 
`hh;Nkhd;fspd; xOq;fhd Row;rp Kiw: 
%is
 ghypf;fpy; ];LKNybq;             xbidrpq; `hh;Nkhd; Ruf;fg;gLfpwJ    
`hh;Nkhd; Ruf;fg;gLfpwJ    
       
      
mz;lfk; 
 i`Nghjyhk]pypUe;J   
n`hNdhNlhlNuh/gpd; hpyprpq; `hh;Nkhd;     
Ruf;fg;gLfpwJ.
         (Jhz;Ljy;) 
Md;bhpah; gpl;ba+l;lhpapypUe;J 
fpuhDNyhrh nry;iy        jPfhnry;iy   Jhz;LfpwJ.   
Jhz;LfpwJ. 
(mNuhkNl]; vd;irk; 
          
  fUKl;il              Md;l;Nuh[d; 
 tsh;r;rp milfpwJ   (Md;l;Nuh];lhapbd;) 
              <];l;Nuh[d; 
Ruf;fg;gLfpwJ 
nrf;];` hh;Nkhd; igd;bq; FNshGspd; nl];Nlh];Buhd;. 
kw;Wk; <l;];Nuh[Dld;          gpize;J 
mjd; Ntiyia
rkepiyapy; itf;fpwJ. 
mz;lfePH;f;fl;b Nehapdhy; `hh;Nkhd;fspy; Vw;gLk; khWghLfs;: 
    
       
ghypfpd; ];LKNybq; `hh;Nkhd       Ybidrpq; `hh;Nkhd;   ; Fiwe;j 
msT mjpfmsT                   Ruf;fg;gLfpwJ   
Ruf;fg;gLfpwJ 
                 jPfhnry;iyJhz;LfpwJ 
                 mjpfmsT Md;l;Nuh[d;  
             (nl];Nlh];Buhd;) Ruf;fg;gLfpwJ 
nrf;];` hh;Nkhd; igd;bq; FNshGspd;msT FiwfpwJ.         
(rhjhuzkhf ,e;j FNshGspd;
                 nl];Nlh];Buhd; kw;Wk; <l;];Nuh[Dld;          
gpize;J mjd; Ntiyia 
                                             rkepiyapy; itf;Fk;)
mjpf mstpy; <l;];Nuh[d;
                
 khjtplha; gpur;ridfs; (khjtplhapd;ik Fiwe;j msT khjtplha;> mjpf 
msT khjtplha;) 
mjpf msT ,d;Rypdhy; 
   (mjpf msT ,d;Rypdhy; nyg;bd; vd;w Gujk; 
   mz;lfj;jpypUe;J Ruf;fg;gLfpwJ. 
i`Nghjyhk]pypUe;J
      
   
n`hNdhNlhl;Nuhgpd; upyprpq; `hh;Nkhd; mjpf msT Ruf;fg;gLfpwJ. 
Md;l;bhpah; gpl;ba+l;lhpypUe;J 
mwpFwpfs;:
1. xOq;fw;w khjtplha; 
• xU tlj;jpw;F Fiwe;j 8 khjtplha; Row;rp 
• mjpfg;gbahd ,uj;jNghf;F (nkdNuh[pah)  
• Fiwthd ,uj;jNghf;F (i`NghnkNdhhpah) 
• khjtplhapd;ik 
(vnkNdhhpah)
2. cly;gUkd; mjpfhpj;jy; 
3. Kfg;gU Vw;gLjy; 
4. `ph;Rbrk;:
   Njitaw;w Nuhk  tsh;r;rp ( cjLf;F Nky;> 
fOj;J fd;dk;> Nky; kw;Wk; fPo; tapw;wpy; ) 
fhzg;gLk;. 
6. tOf;ifj;jd;ik Vw;gLjy;  
7. ngz;Fwp%y tPf;fk; 
8. vfhd;Njhrp]; ief;hpad;]; 
 if, fOj;J ,tw;wpy; fUg;Gepw gl;ilfs; fhzg;gLk;. 
fz;lwpAk; Kiwfs;: 
1. FLk;g jfty; mwpjy;: 
• guk;giu rh;f;fiu tpahjp> guk;giu mz;lf ePH;f;fl;;b Neha; gw;wpa 
jfty;fis Nrfhpf;f Ntz;Lk;. 
• cly; vil mjpfhpg;G> khjtplha; Row;rp  gw;wpa jfty;fis Nrfhpf;f 
Ntz;Lk;. 
2. ,uj;jNrhjid
      `hh;Nkhd;fspd; msTfis  Nrhjid nra;a 
Ntz;Lk;. 
• nl];Nlh];Buhdpd; msT 70mg/dl f;F Nky; 
mjpfkhFk; NghJ mz;lf ePH;f;fl;b Neha; Vw;gLk;. 
• Ybidrpq; `hh;Nkhdpd; msT 25Iu/l f;F Nky; 
mjpfkhdhy; mz;lf ePH;f;fl;b Neha; Vw;gLk;. 
• nrf;]; `hh;Nkhd; igz;bq; FNshGspd;  
144nmol/2 f;F FiwAk; NghJ mz;lf ePH;f;fl;b Neha; Vw;gLk; 
• ,d;Rypd; msT 50units f;F mjpfkhFk; NghJ ,d;Rypd; vjph;g;G 
Vw;gLfpwJ. 
•
3. fh;g;gig kw;Wk; tapW my;l;uhrTz;l; ];Nfd:; 
    ,J mz;lf ePH;f;fl;b Nehapid fz;lwpAk; 
Kf;fpakhd Nrhjid MFk;. ,jpy; ePh;f;fl;bapd; 
msit fhzyhk; 
rpfpr;ir Kiwfs;;:
1. tho;f;if Kiw khw;wq;fs;  
2. kUj;Jt rpfpr;ir  
3. mWit rpfpr;ir  
1.tho;f;if Kiw khw;wq;fs;  
(Kjd;ik tifahd rpfpr;ir Kiwfs;) 
• clypd; vilia Fiwg;gjd; %yk; mz;lf ePh;f;fl;bapd; 
tpisTfis Fiwf;fyhk;. 
• clypd; vilia> czT kw;Wk; clw;gapw;rp %yk; Fiwf;fyhk;. 
• clypd; vilia fzf;fpl ,e;j Rj;jpuj;ij gpd;gw;wTk; 
BMI
,jd; kjpg;G  
        <18.5            – kpfTk; Fiwthd vil 
                   18.5 – 24.9   - rupahd vil
                   25 – 29.9      -  mjpfkhd vil
                   >30               - kpfTk; mjpfkhd vil 
Nru;j;Jf; nfhs;s Ntz;ba czT 
tiffs;
vLj;Jf;fhl;L
1.KOikahd czT nghUl;fs; 
2.ehh;r;rj;J epiwe;j czTg;nghUl;fs;: 
 ehh;rj;J epiwe;j czTg;nghUl;fis 
jpdKk; rhyLfshf rhg;gplyhk;. 
goq;fs; 
fha;fwpfs;
3.Gujr;rj;J epiwe;j czTg;nghUl;fs; 
Kl;ilNfh];> 
nfhl;ilfs; 
mtiugPd;]; 
Mg;gps;
gUg;Gtiffs; 
kPd;
Fiwthf Nru;j;Jf; nfhs;s Ntz;ba 
czT tiffs; 
vLj;Jf;fhl;L
1.Fiwe;j nfhOg;G rj;J cs;s 
czTg;nghUl;fs;:
(xU ehisf;F 74.8 fpuhKf;F 
Fiwthf) 
2.Fiwe;j msT rh;f;fiu cs;s 
czTg;nghUl;fs;: 
nrwpt+l;lg;glhj vz;nza; (kf;fhNrhsh 
vz;nza;)
,dpg;G tiffs; 
rh;f;fiuf;F gjpyhf fUg;gl;b Nrh;j;J 
nfhs;syhk;  
ghpe;Jiuf;fg;gl;l tho;f;if Kiw khw;wq;fs;:
1.cly; vil FiwT 5-10%
2. Fiwe;j msT fhh;Nghi`l;Nul; epiwe;j czTg; nghUl;fs; 
3. mjpf msT ehh;rj;J epiwe;j czTg; nghUl;fs; 
4. Fiwe;j msT nfhOg;G rj;Js;s czTg;nghUl;fs; 
5. fhh;Nghi`l;Nul;> Gujk; kw;Wk; nfhOg;G Nrh;e;j rhptpfpj czT 
6. rpwpa mstpy; mbf;fb czT vLj;J nfhs;Sjy; (jpdKk; 4-5 
Kiw)
3.Fiwe;j msT fhh;Nghi`l;Nul; 
cs;s czTg;nghUl;fs; 
4.Fiwe;j msT cg;G: 
rhjk; (xU ehisf;F xU Kiw kl;Lk 
NghJkhdJ) 
cUisfpoq;F  
xU ehisf;F 2400 kpy;ypfpuhk;f;F 
Fiwthf cg;G vLj;J nfhs;s 
Ntz;Lk;
cg;Gf;F  gjpyhf vYkpr;ir> kpsif 
Nrh;j;J nfhs;shk;. 
   
clw;gapw;rp:
1. tPl;L Ntiyfspy; <Lglyhk;. 
2. jpdKk; miukzp Neuk; clw;gapw;rp 
nra;a Ntz;Lk;. 
   (nkJthf clw;gapw;rp nra;Ak; Neuj;ij 
mjpfg;gLj;jyhk;) 
gpur;idfs; Rpfpr;ir Kiwfs; gad;fs; 
xOq;fw;w 
khjtplha; Row;rp: 
fUTWjy; 
gpur;ridfs; 
`hh;Nkhd; khj;jpiufs; 
(hormone tablets) 
/g;Nuhn[];bpuhd; khj;jpiufs; 
(g;Nuhn[]b;d;) (progestin)
nkl;ghh;kpd;  
(metformin)
1.FNshkpNgDld;
nkl;ghh;kpd;(clomifene with metformin) 
2.FNdhNlhl;NuhgPd; khj;jpiufs; 
(nguf;dpy;) 
`hh;Nkhd 
khj;jpiufs; kw;Wk; 
g;Nuhn[]b;uhd; 
khj;jpiufs;
i`Nghjyhkpf;  - 
gpl;ba+l;lhpapd; 
xOq;fw;w 
nray;ghLfis jLj;J 
mz;lfj;jpypUe;J 
mz;lk; ntsptUtij 
Jhz;LfpwJ 
nkl;ghh;kpd; ,d;Rypd; 
vjpHg;ig jLf;fpwJ. 
   
,it ghypfps; 
];LKNybq; 
`hNkhdpd; msit 
mjpfhpj;J
mz;lfj;jpypUe;J 
mz;lk; ntsptUtij 
 Jhz;LfpwJ 
Njitaw;w 
Nuhk tsh;r;rp 
xUq;fpize;j `hh;Nkhd; khj;jpiufs; 
(ilandl;Nlh) (dianette) 
v/g;Nyhh;hpjPd; fphPk; (eflorithine cream) 
/GSlikl;(flutamide) 
];iguNdhyf;Nlhd; 
(spiranolactone)
Nrtpq;
Nyrh; 
,it midj;Jk; 
nl];Nlh];Buhd; 
`hh;Nkhdpd; msit 
Fiwe;j Njitaw;w 
Nuhktsh;r;rpia 
Fiwf;fpwJ. 
Njitaw;w Nuhk 
tsh;r;rpia Nrtpq;> Nyrh; 
%yKk; Fiwj;J 
nfhs;syhk;. 
mz;lf ePH;f;fl;b Neha; ghjpg;gpd; rpy tpisTfs;: 
1.rh;f;fiu tpahjp (tif II )
Kfg;gU
mWit 
rpfpr;ir: 
1.vNkhypad;]; vd;w fpHPik 
gad;gLj;jN
tz;Lk;. 
2.jpdKk;
Kfj;ij 2-3 
Kiw fOt 
Ntz;Lk; 
(mjpfkhf
fOtf; 
$lhJ.) 
3.nfhOg;G rj;J epiwe;j 
czTg;nghUl;fis jtph;f;f 
Ntz;Lk;. 
xNthpad; ilanjh;kp –
yhg;Nuh];Nfhgpf; XNthpad; bhpypq; 
yhg;Nuh];Nfhgpf;
%ykhf mz;lfj;jpy; 
nl];Nlh];Buhid 
cUthf;Fk; jpRf;fis 
Nyrh; my;yJ ntg;gk; 
%yk; mopj;J 
mz;lfj;jpd; 
,ay;Gepiy kPz;Lk; 
nfhz;L tug;gLfpwJ. 
2.Foe;ijapd;ik 
3.fh;g;gig Gw;WNeha; 
4.cah; ,uj;j mOj;jk;  
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